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Every cell has its distinct phenotype, behavior and function. However, 
conventional biological analytical assays, such as western blot and enzyme-
linked immunosorbent assay, adopt ensemble measurements to extract the 
average information from non-homogeneous cell populations without taking 
into account the critical details of individual cells. Such simplistic methods 
could generate misleading results from highly heterogeneous cells, like cancer 
and immune cells. In order to accurately and effectively study functional 
heterogeneity of single cancer and immune cells, we developed a series of 
microfluidic droplet platforms. We first developed a novel and label-free 
droplet system to enhance single-cell encapsulation efficiency by incorporating 
jetting and size-based sorting. The device consistently achieved above 70% 
single-cell efficiency for a wide range of input cell concentrations, which broke 
the Poisson prediction on random encapsulation process. Next, we applied the 
droplet microfluidics to study single-cell matrix metalloproteinase activity of 
various breast cancer cell lines and patient-derived circulating tumor cells. It 
was discovered that the proteolytic activity level was positively correlated with 
invasiveness and metastatic potential of cultured cell lines. The assay results of 
in-vitro cultured circulating tumor cells revealed great cellular heterogeneity, 
reflecting diverse treatment responses on patients undergoing the same type of 
treatment. Lastly, we developed a new droplet microfluidic system to study 
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matrix metalloproteinase of single leukocytes with solving the pre-
encapsulation contamination issue, which was a serious problem for single 
leukocyte study. By integrating a cell washing channel in front of a droplet 
generator, we successfully suppressed the background signals of empty droplets 
and accurately detected the proteolytic activity of individual leukocytes under 
naïve and drug-treated conditions. Overall, we managed to use droplet 
microfluidics to probe the proteolytic activity of cancer and immune cells at the 
single-cell level. The acquired proteolytic profile could facilitate diagnosis of 
diseases, surveillance of drug responses and development of treatment strategies. 
The droplet technology holds a great potential in personalized medicine to 
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CHAPTER 1. Introduction  
1.1 Overview 
Nature has never been known to make any exact duplicates. Gottfried Wilhelm 
Leibniz, a German philosopher and mathematician, stated any two distinct 
things cannot have all their properties in common. In the Principle of Identity 
of Indiscernibles, he suggested that if two entities are alike in every aspect, they 
are essentially the same object. Leibniz elaborated on this rule using leaves, 
claiming there are no two leaves exactly alike.  
Likewise, the same principle also applies to the fundamental building blocks of 
our body – cells. No two cells are exactly identical. Each cell has its distinct 
phenotype, behavior and function even when compared to other cells from the 
same lineage or sharing the same gene. The collaborative efforts of different 
cells contribute to a comprehensive list of tissue functions and help to maintain 
the healthy status of the human body.  
Researchers today are increasingly aware of the importance of heterogeneity in 
cell samples, especially for clinical applications. Heterogeneous diseased cells 
are difficult to be specifically targeted all at once by a single drug. Furthermore, 
heterogeneous drug responses make treatment efficacy vary dramatically across 
different patients. Research in characterizing cellular heterogeneity allows a 
better understanding of disease status, leading towards more reliable diagnostics 
and accurate therapeutics.  
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Despite the importance of cellular heterogeneity, technological limitations 
restrict conventional biological assays to adopt the simplistic method of 
extracting averaged properties from non-homogeneous cell populations. 
Thousands, if not millions, of cells are studied together in an ensemble manner 
using tools such as western blot and enzyme-linked immunosorbent assay 
(ELISA). For many decades, life scientists have acquired significant biological 
knowledge relying on such technology by studying seemingly identical cells.  
Genetic patterns and protein expression can explain cellular behavior to a large 
extent based on assaying a population of cells. However, the ensemble 
characteristics of a cell population may not represent the characteristics of any 
individual cell, especially for highly heterogeneous cell types such as cancer 
and immune cells. These cells usually have a diverse composition with many 
subpopulations present together. 
In order to study cellular heterogeneity, new technology must be developed to 
study the behavior of individual cells by isolating them from complex multi-
cellular organisms. This newly-established research area is known as single cell 
analysis (SCA). Indeed, some single-cell analysis methods have been readily 
available in the market. However, their functionality, throughput and cost-
effectiveness are still largely constrained by various technological limitations.  
Due to the recent advancement of microfabrication technology, many 
microfluidic devices, also known as lab-on-a-chip (LOC), have been developed 
to perform various biological assays at micro-meter scale. Microfluidics has 
3 
 
gained unique research interest in single-cell analysis because it requires small 
volume of sample and reagent (usually in micro-liter (µL) scale), reduces 
process and response time, and increases assay sensitivity as well as accuracy. 
The essential approach adopted in microfluidic single-cell analysis is to create 
cell compartments to isolate individual cells so that assays at single-cell 
resolution can be achieved. Till now, many of the single-cell microfluidic 
approaches have been developed using four main compartmentalization 
techniques: hydrodynamic trap, microwell, valve-assisted microchamber, and 
droplet system.  
Compared with various single-cell microfluidic technologies, the droplet-based 
system is fit for study of metabolism and biomolecule secretion at single-cell 
level. This method suspends cells in water-in-oil emulsions, effectively 
preventing contamination across droplets. Cells trapped in droplets are 
completely isolated from other cells and ambient environment. Meanwhile, the 
metabolites and biomolecules produced by cells are confined within pico-liter-
volume droplets and can accumulate to high concentrations for downstream 
analysis. It is hence evident that droplet-based technology holds a great potential 
to study functional heterogeneity of cell samples, particularly minute amounts 
of clinical samples.  
This PhD project aims to explore how to accurately and effectively perform 
droplet-based single-cell functional analysis on proteolytic activity, especially 
matrix metalloproteinase (MMP) activity. Proteolytic activity of cells plays a 
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significant role in cell migration, tissue remodeling and immune response [1, 2]. 
It has broad clinical implications in fetal development, wound healing, cancers, 
inflammation, etc. A series of droplet-based microfluidic devices have been 
developed and exploited to probe cell-to-cell variation of single-cell proteolytic 
activity (e.g. matrix metalloproteinases activity). The assay targets of this entire 
PhD work include cultured cancer cell lines, patient-derived cultured circulating 
tumor cells (CTCs) and freshly-retrieved white blood cells (WBCs). The 
obtained single-cell proteolytic information could be helpful in evaluating 
proteolytic heterogeneity of cell populations and contribute to disease diagnosis 
and surveillance. With further development on throughput and detection 
sensitivity, the droplet-based single-cell assay technique could become a 
versatile and powerful tool to examine primary patients’ samples and provide 
critical information on proteolytic and other cellular functions at the single-cell 
level. I believe this technique would play a great role in personalized medicine 
as well as fundamental life science research in a short future.  
 
1.2 The motivation and hypothesis  
We would like to apply droplet-based microfluidics to perform proteolytic 
functional study on living single cancer cells and leukocytes. New functions 
would be built on top of the existing technology in order to resolve some current 
technological limitations: 1) low single-cell encapsulation rate and 2) high pre-
encapsulation contamination. Additionally, patient-derived cancer cell samples 
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would be investigated using droplet microfluidics as a proof-of-concept for 
clinical application.  
With this aim in mind, we focus on verifying three hypotheses in the PhD 
dissertation: 
Hypothesis 1: size-based droplet sorting can be utilized to enhance single-cell 
encapsulation rate for samples with low cell concentration. 
We will apply jetting technique to create a size difference between 
empty and cell-containing droplets before using size-based sorting to 
remove empty ones. 
Hypothesis 2: droplet-based single-cell assay could be used to detect matrix 
metalloproteinase (MMP) activity of cultured cancer cell lines and cultured 
circulating tumor cells (CTCs), which could be correlated to metastatic potential.  
We will first develop an in-vitro CTC culture device and then 
encapsulate the cultured CTCs obtained from different patients into 
droplets to perform single-cell functional MMP assay. 
Hypothesis 3: cell washing can be implemented before cell encapsulation to 
purify target cells from soluble contaminants that are secreted by the target cells 
prior to the assay, resulting in more accurate downstream analysis. 
We will adopt size-based sorting design to achieve cell purification 
under laminar flows. Subsequently, the washing function will be 
integrated with a droplet generator to encapsulate each purified cell into 
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a droplet for downstream MMP analysis. 
 
1.3 Scope of work 
The scope of the dissertation is confined to the use of droplet microfluidic 
system to perform single-cell proteolytic analysis. The proteolytic activity of 
human cells will be studied using the developed droplet platforms as suggested 
in the hypothesis. The measured activity at single-cell level will provide 
important insights of cellular heterogeneity which in turn aids in accurate cell 
behavior evaluation and precise personalized medicine. Both cancer cells and 
leukocytes will be used in the project to prove the concept and application for 
medical diagnostics. 
 
1.4 Summary of chapters 
Following this introduction is a chapter on literature review. It first gives an 
overview of cellular heterogeneity, including the cause and significance. Recent 
research on both cancer and immune heterogeneity, the two foci of this 
dissertation, is then summarized. Based on the clinical implications of cancer 
and immune heterogeneity, the importance of performing single-cell analysis 
(SCA) on cancerous cells and immune cells is highlighted. Conventional macro-
scale single-cell analysis technologies, including their working principles and 
inescapable limitations, are briefly discussed. Subsequently, various 
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microfluidic single-cell technologies will be discussed to provide a 
comprehensive review on this emerging research area. Eventually, we would 
elaborate the reasons why we have selected droplet technology to fulfill the task 
of single-cell functional analysis. 
Chapter 3 next focuses on how to increase single-cell encapsulation efficiency 
using passive droplet sorting. We created size difference between cell-
containing droplets and empty droplets using jetting. Empty droplets were next 
separated out in the deterministic lateral displacement (DLD) isolation array for 
effective downstream analysis. As passive size-based sorting was implemented, 
no external power source was necessary to conduct the sorting function. More 
importantly, original cell status was preserved since no immunochemical 
labeling was required in this system. The enrichment performance on single-
cell encapsulation efficiency was independent of input cell concentration, which 
is largely favorable for clinical applications because clinical samples are usually 
low in cell count. The droplet device was applied to study proteolytic function 
of cultured cancer cell lines and conduct single-cell drug screening. 
However, the first-generation of droplet device still had some drawbacks to 
perform accurate functional assay on rare patient-derived samples. Therefore, 
in chapter 4 in-vitro CTC culture was utilized to expand the cell population to a 
desirable level for droplet-based assay. Several breast epithelial cell lines, 
originated from breast cancerous and healthy tissues, were analyzed using 
droplet technology. The proteolytic activity acquired from single breast cells 
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revealed that metastatic cancer cells had a more intensive proteolytic activity 
profile than non-invasive cancer cells and healthy epithelial cells. Next, cultured 
CTCs derived from breast cancer patients and lung cancer patients were 
carefully studied in the functional assay, revealing the huge heterogeneity in the 
cultured CTC samples.  
When studying cultured CTC samples, we always found some leukocytes 
present with cultured CTCs and they had similar proteolytic activity levels. 
Therefore, in chapter 5 we conducted a comprehensive MMP study on single 
leukocytes. Unlike cancer cells, leukocytes are highly active in protease 
production due to their duty in immune defense. Consequently, direct assay on 
leukocytes encountered a big challenge on pre-encapsulation contamination. To 
solve this problem, we developed a cell-washing channel to purify target cells 
before they were encapsulated into droplets. By incorporating the on-chip 
washing function with droplet generator, clean signals of single leukocytes were 
successfully detected from droplets. Excellent signal-to-noise ratio enabled 
rigorous functional study on single leukocytes under naïve and PMA (phorbol 
12-myristate 13-acetate)-mediated status. The results indicated that PMA 
treatment not only elevated the protease production but also stimulated the cell-
to-cell variance.  
Lastly, a summary of this dissertation is provided in the final chapter together 
with the outlook of future development. The outcomes of this dissertation have 
been presented in international and domestic conferences in the field of 
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microfluidic technology. Some of the chapters have also been published in or 
submitted to recognized peer-reviewed journals.  
Chapter 2. Literature review 
2.1 Cellular heterogeneity and need for single-cell analysis  
Cellular heterogeneity describes the fact that any two cells can own distinct 
morphological and phenotypic profiles. People used to think isogenic cells that 
have uniform genetic make-up, such as cell lines, are identical in all aspects. 
However, after decades of probing and analyzing the behaviors of single cells, 
substantial evidences have shown that considerable heterogeneity can exist even 
within isogenic cell populations [3-5]. For example, monozygotic twins that 
stem from one split zygote still have some distinct features.  
What is the reason for the occurrence of cell-to-cell difference within the same 
cell type? First of all, cell cycle can contribute to the cellular heterogeneity in 
many ways. Cell morphology, metabolism and protein expression of the same 
type of cell vary at different stages of cell cycle [6, 7]. For instance, the 
expression of proteins, implicated in cell cycle regulation and DNA replication, 
relatively increases at interphase stages in contrast to G0 stage [8]. Apart from 
cell cycle, genetic drift can also increase the heterogeneity within a cell 
population [9]. When a cell is proliferating, variations in gene replication can 
occur randomly, which lead to a different daughter cell. This process is known 
as mutation. Furthermore, epigenetic modifications that functionally change 
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gene expression via DNA methylation and histone modification can lead to 
different phenotypes of cells that share the same DNA sequence [10]. 
Although phenotypic differences among cells are always present at a fine-
enough resolution of investigation, population-averaging assays are still 
predominant tools in biology. This is because the average behavior of a cell 
population may be summarized by a mean value, revealing important biological 
information of all cells within the same cell type. Cell-to-cell differences in 
some cases may not have any functional significance, for example those due to 
biochemical noise or environment fluctuation [11, 12].  
However, cell-to-cell differences can have functional consequences as observed 
in the random development of antibiotic resistance in the same strain of bacteria 
[13]. Subpopulation of stem-like cells was recently identified from human 
breast cancer cell lines to give rise to phenotypically diverse progeny and 
survive through a course of chemotherapy [14]. Therefore, models derived from 
a population average may yield misleading results because ensemble 
measurement does not account for critical details of individual cells as shown 




Figure 2.1 Comparison between ensemble analysis and single-cell analysis on a 
heterogeneous cell population. Ensemble analysis generates average signal 
based on the predominant cell population. However, single-cell analysis reveals 
precious details of minor cell subpopulations. 
Capturing functional details of individual cells becomes increasingly critical in 
clinical applications. Unlike cultured cell lines, clinical samples are not 
homogeneous, consisting of multiple subpopulations. Mixed cell populations 
greatly increase cellular heterogeneity and cannot be accurately represented by 
population averages. The cell-to-cell variation is one of the keys to answer 
previously irresolvable questions in cancer research, stem cell biology, 
immunology, developmental biology, and neurology [15-17]. In order to acquire 
the details of cell-to-cell difference, single-cell analysis technology is essential 
to enable scientists to look at the world beneath population averages of 
seemingly identical cells.  
 
2.2 Cancer and its heterogeneity 
Cancer is one of the world’s deadliest human diseases. This disease stems from 
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cell lesions that enable abnormal cell growth with the potential to spread to 
distant organs in the body. Cancer has created huge economic and healthcare 
burdens to the society. In 2012, there were 14.1 million new cases of cancer and 
8.2 million deaths from cancer in the world [18]. The incidence rate is about 
185 new cancer cases for every 100,000 people and the mortality rate is about 
105 cancer death for every 100,000 cancer patients [19].The number of cancer-
related deaths is now increasing at a rapid rate due to the extended life 
expectancy of our aging population, unhealthy lifestyles and obesity [20].  
Normal cells always run through an orderly process of growth and proliferation.  
When they grow old or become damaged, they undergo apoptosis and new cells 
take their place. Certain mutations in cells may lead to the upregulation of 
oncogene or downregulation of tumor suppressor gene. Consequently, old or 
damaged cells are able to escape from programmed death by growing and 
dividing uncontrollably, eventually forming a cancerous tissue also known as a 
tumor.  
Cancer presents significant heterogeneity both between tumors (inter-tumor 
heterogeneity) and within tumors (intra-tumor heterogeneity) [21]. Cancer 
occurring at the same organ differs among patients with distinct mutations. 
Cancer cells within one tumor site show different phenotypic characteristics due 
to different microenvironment influence and accumulation of different 




Figure 2.2 Illustration of the development of intra-tumor heterogeneity. 
Subclonal tumor cell populations carry diverse mutations that might be different 
from the initial tumor cell population. (Adopted from Layla Oesper’s website 
from Carleton College) 
As tumor cells proliferate, their DNA tends to accumulate more mutations. 
Some of the mutations enhance the invasiveness of tumor cells and turn benign 
tumors to malignant. Such mutations enable cancerous cells to break off from 
the primary tumor site and spread into distant tissues to form secondary tumors. 
The dissemination of malignant tumor cells is known as cancer metastasis [22]. 
These self-renewal tumorigenic cells leading to metastasis is known as cancer 
stem cells (CSCs) [23]. 
Many therapeutic methods have been developed to stop cancer cells from 
growing and metastasizing to other organs. However, the heterogeneity of tumor 
cells imposes significant challenges in finding effective treatment approaches. 
When treated with cancer drugs, some resilient tumor cells can develop bypass 
mechanism to counter the inhibitory effect of the drug, resulting in treatment 
failure and cancer relapse [24].  
Research into investigating and characterizing tumor heterogeneity can provide 
14 
 
a better understanding of disease status. In turn, the knowledge of cancer 
heterogeneity can guide the creation of diagnosis and treatment strategies with 
better accuracy and higher efficacy. In order to effectively analyze tumor 
heterogeneity, the resolution of biological assay must be improved to single-cell 
level to differentiate the cell-to-cell variation and identify the aggressive 
subpopulation of cancer cells from other non-tumorigenic cells. 
 
2.3 Leukocyte and its heterogeneity 
Apart from cancer cells, leukocytes, also known as white blood cells, are also 
highly heterogeneous and clinically important. Leukocytes are one of the 
hematological cells that circulate throughout the human body. Unlike the other 
two hematological cells, erythrocytes (red blood cells) and platelets, all 
leukocytes have nuclei. The normal concentration range of leukocytes is 5 to 10 
million per milliliter of blood. They make up approximately 1% of the total 
blood volume in a healthy adult, substantially less than erythrocytes at 40 to 
45%. The size of a leukocyte varies from 10 to 30 μm.  
Leukocytes can be divided into different classes including neutrophils, 
eosinophils, basophils, lymphocytes and monocytes based on their 
morphological and functional characteristics (figure 2.3). Additionally, 
neutrophils, eosinophils and basophils are grouped as granulocytes because of 
the presence of granules and lobed nuclei. Among all subclasses, neutrophils are 
the most abundant cells accounting for approximately 60% of the total 
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leukocytes, followed by lymphocytes at approximately 30%.  
Leukocytes are the cells of the immune system that are involved in protecting 
body against invaders such as bacteria and virus. As the frontline of immune 
defense, leukocytes play multiple roles in immune response and host protection. 
Neutrophils primarily defend against bacterial and fungal infection as the first 
responder in the innate immune system. Eosinophils mainly fight against 
parasitic infections while basophils are predominantly responsible for allergic 
response. T and B lymphocytes play key roles in the adaptive immune system. 
Last but not least, monocytes chiefly eliminate debris and pathogens.  
 
Figure 2.3 (Left) Illustration of blood composition. Hematological cells include 
red blood cells, white blood cells and platelets. (Right) Subpopulations of white 
blood cells based on their different morphologies and functionalities (adopted 
from Wikipedia). 
Without doubt, cellular heterogeneity is present among various subtypes of 
leukocytes. Different subgroups of leukocytes have been associated with 
inflammatory response, autoimmune disease and cancer progression [25-27]. 
Functional heterogeneity has also been observed within the same subtype of 
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leukocytes. Differential priming effects of pro-inflammatory cytokines on 
neutrophil were detected in response to bacterial N-formyl peptide [28]. Varied 
oxidative responses of subpopulation of neutrophils were demonstrated between 
healthy subjects and patients with rheumatoid arthritis [29]. More recently, 
different pro- and anti-inflammatory roles of leukocyte subsets were 
investigated in models of tumor microenvironment [30].  
Characterization of individual leukocyte secretion profiles, such as the protease 
profile, is important to reveal the functionality of the immune system and 
provide insights into personal physiological conditions for precision medicine. 
For example, protease MMP-8 produced by neutrophils has been shown to 
promote leukocyte recruitment to fight against bacteria in sepsis [31]. Protease 
MMP-9 from leukocytes has been found to facilitate basal membrane 
degradation and promote cancer development [32]. Moreover, several 
autoimmune diseases such as asthma and rheumatoid arthritis, have been 
associated with abnormal protease secretion [33, 34].  
Diverse functionalities of leukocytes suggest different treatment strategies must 
be developed in order to optimize immune response and enhance drug efficacy 
[35]. Therefore, single-cell analysis technology is in a great demand to probe 
the cell-to-cell variance in term of heterogeneous leukocyte functionalities for 




2.4 Conventional methods for single-cell analysis 
As the awareness of biological significance of cellular heterogeneity increases, 
the need of single-cell analytical methods becomes urgent. The easiest method 
of doing single-cell assay is to pipette single cells into a microwell plate (e.g. 
96 well plate) with proper dilution. In this way, single cells are spatially 
confined into individual wells and ready for any downstream analysis. However, 
this technique has many practical issues including uncontrollable single cell 
dispersion and limited detection sensitivity due to dilution.  
To realize experiments at the single-cell level, many analytical technologies 
have been developed to manipulate and analyze one cell at a time. Some force 
cells to pass through a narrow channel so that single-cell observation resolution 
can be achieved. Others miniaturize the manipulation tools to micrometer scale 
so that they can directly handle single cells. Here, we classify these conventional 
macro-scale technologies into two groups according to the cell properties to be 
measured, namely biochemical and biophysical analytical methods.  
2.4.1 Biochemical single-cell analytical method 
Flow cytometry, first invented in 1953, is one of the most popular single-cell 
analytical tools that has been routinely used in the diagnosis of blood disorders 
and fundamental biological research [36]. The flow cytometer mainly measures 
the expression of biochemical markers on the surface of individual cells (figure 
2.4(A)). It consists of a cell dispersion module and a light detection module. 
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Before loading into the flow cytometer, the cell sample is immunochemically 
stained with antibodies conjugated with different fluorophores. The labeled cell 
sample passes into a narrow cell dispersion channel together with sheath flow, 
which allows only one cell to pass through the detection point at one time. Based 
on the fluorescence intensity detected by photo sensors, the expression level of 
certain surface biomarkers can be analyzed quantitatively. 
The measured expression results can assist in identifying unknown cells, 
discovering new biomarkers for specific cell types and correlating with 
phenotypic characteristics. For example, researchers identified CD44+/CD24-
/Lin- breast cancer cells to have significantly improved tumor forming ability 
in NOD/SCID mice compared with CD44+/CD24+/Lin- cells [37] using flow 
cytometry. Moreover, using the same tool, a subset of neutrophils with 
CD11c+/CD62L-/CD11b+/CD16+ expression was reported to have the ability 
to inhibit T cell response to macrophage integrin MAC-1 in systemic 
inflammation [38].  
Although flow cytometry is a high-throughput technique to monitor multiple 
characteristics of single cells spontaneously, its major limitations include 1) 
poor cell viability, 2) limited detection targets due to overlapped fluorescent 
spectrum, 3) high equipment and maintenance cost due to complicated system 
design, and 4) incapability of acquiring functional information and monitoring 
cell behaviors, apart from surface marker expression.  
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Mass spectrometry is another powerful analytical technique to analyze 
biomolecules that can be applied for single-cell analysis. Unlike flow cytometry 
measuring optic signals, a mass spectrometer measures the mass-to-charge ratio 
of ionized biochemical species such as proteins and peptides (figure 2.4(B)) [39]. 
Since different biomolecules possess distinct mass-to-charge signatures, the 
abundance of target molecules present in the sample can be quantitatively 
determined. Usually, mass spectrometry is used to analyze biological specimen 
obtained from a population of cells, for instance the lysate from a group of cells.  
With appropriate modifications, a mass spectrometer can also be used to analyze 
protein expression and metabolism at single cell level. Nemes’s group has 
demonstrated that single-cell electrophoresis-electrospray ionization mass 
spectrometry can be used to identify 40 metabolites from single embryonic cells 
[40]. The differential concentration of some metabolites leads to different tissue 
fate in the embryonic development revealing the metabolome affects cell 
phenotypes in the embryo [40]. In another study, live single cell mass 
spectrometry has been reported for the analysis of large numbers metabolites to 
disclose dynamic molecular mechanisms [41]. A high resolution mass 
spectrometer was even able to measure 20ng of protein content in single 
embryonic cells [42]. 
Mass spectrometry is a powerful analytical technique with high detection 
resolution on small volume of sample, but it has limited applications beyond 
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basic research. The main constraints include 1) complicated system with high 
cost, 2) low throughput due to purification process such as liquid 
chromatography and electrophoresis, and 3) incapability of recovering cell due 
to cell destruction during the sampling process. 
Apart from using flow cytometry and mass spectrometry separately, researchers 
can also combine both techniques to develop mass cytometry with improved 
single-cell analysis function. The limitation on fluorescent spectrum can be 
overcome by replacing the fluorescent labeling with isotope labeled antibodies. 
The number of distinguishable labels can be increased beyond 30 which means 
more than 30 kinds of biomolecules can be monitored at one time, far more than 
normal cytometry [43]. This combined technique has been implemented on 
bone marrow and cancer studies with superior resolution [44, 45]. 
 
Figure 2.4 (A) Scheme of flow cytometry where single cells are detected based 
on their light scattering signals and fluorescent labelling (adopted from Semrock 
website) (B) Scheme of mass spectrometry to study proteins and metabolites 
produced by single cells (adopted from slideplayer.com). (C) A series of images 
showing micropipette aspiration of a cancer cell to study cell stiffness [46]. (D) 





2.4.2 Biophysical single-cell analytical method 
Biophysical, or biomechanical, property of cells often refers to cell stiffness and 
is mainly attributed by actin filament and cytoskeleton [48]. The biophysical 
characteristics of cells have drawn research attention in the recent years because 
many studies suggested the stiffness of cells has significant implications in 
physiological and pathological conditions. Softer breast cancer cells are deemed 
to be more invasive as they can remodel their morphology and squeeze through 
tissue membrane and blood vessels easily [49]. Therefore, many techniques 
have been developed to specifically study biophysical properties at single-cell 
level. The common ones include micropipette aspiration, atomic force 
microscopy (AFM) and optical tweezers (OT).  
Micropipette aspiration is an analytical method to study mechanical properties 
of single cells in which the surface of a cell is aspirated into a small glass tube 
while the deformation of the cell surface is monitored (figure 2.4(C)) [46]. 
Based on the membrane deformation, single cell stiffness could be derived using 
Law of Laplace. Scientists have used micropipette aspiration technique to study 
the correlation between cancer cell stiffness and invasiveness [50].  
Atomic force microscopy (AFM) is a versatile scanning probe microscopic 
technique with nanometer scale resolution. AFM has a spring-like cantilever 
with fine tip fixed to its free end. A beam of laser shines at the back the cantilever 
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and a photo detector records its reflection, indirectly monitoring the motion of 
the cantilever. By touching the sample surface, topographic image of the sample 
surface can be acquired [51]. Apart from imaging, AFM can also be used to 
perform force measurements. In force measurements, a spherical bead is usually 
attached at the AFM tip to indent cells [52]. The local stiffness of a single cell 
at various cell locations (i.e. near nucleus) can be quantified by measuring the 
indentation depth and force exerted on the cantilever.  
Optical tweezers (OT) is another scientific instrument to manipulate single 
biological cells and perform biophysical characterizations. Unlike micropipette 
and AFM, OT applies non-contact force for cell manipulation by creating an 
optical gradient trap [53]. In biophysical characterization, silica beads are 
attached to the target cells. The single-cell stiffness can be induced by exerting 
different optical force to stretch the cell and measuring the cell elongation 
(figure 2.4(D)) [47].  
The conventional analytical techniques for single-cell biophysical assay are 
dedicated to study basic cellular biology and have limited applications at current 
stage. This is mainly because the equipment for single-cell biophysical study is 
bulky and expensive. Furthermore, the current assay time for one single cell can 
reach up to one hour. The single-cell detection process still needs be improved 




Overall, the macro-scale conventional single-cell techniques play a big part in 
basic biological research to examine certain properties of cells, such as surface 
marker expression and stiffness. However, their clinical application has been 
constrained by high system cost, low assay throughput, low detection sensitivity 
and high sample consumption. There is a tremendous need of simple but 
versatile tool probing functional difference on the basis of single cells. 
Microfluidic single-cell analytic techniques have emerged to meet this need. 
 
2.5 Microfluidic methods for single-cell analysis 
The rapid development of microfluidics has enabled accurate and high-
throughput single-cell analysis. Unlike conventional macro-scale techniques 
that rely on sophisticated equipment to manipulate individual cells one at a time, 
most of the microfluidic platforms aim to create parallelized micro-scale cell 
compartment to facilitate single-cell biological assays. Cells are isolated from 
each other so that the behavior of individual cells can be monitored and studied 
separately, which is impossible for ensemble measurements [54]. The resolution 
and sensitivity of microfluidic single-cell assay are also dramatically enhanced 
as unnecessary dilution of target molecules and contamination across different 
cells are prevented. Additionally, miniaturization of single-cell compartment 
systems largely reduces reagent consumption and sample requirement without 
comprising the assay accuracy, thus cutting the cost of single-cell analysis.  
To date, a lot of microfluidic designs have been developed for various 
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downstream single-cell analysis using four main compartmentalization 
techniques: hydrodynamic trap, microwell, microchamber, and droplet 
encapsulation. Here, the working principles of these techniques are explained 
together with their advantages and disadvantages. 
 
2.5.1 Hydrodynamic trap 
Hydrodynamic trap, one of the earliest microfluidic designs, uses barriers to 
capture single cells suspended in fluid. Cells are brought to microfluidic traps 
by flow. Once a trap site is occupied by a cell, new incoming cells will have to 
bypass the occupied trap and be captured by following empty traps as shown in 
Figure 2.5(A). As cells are trapped at different positions, single-cell phenotype 
and behavior can be easily monitored. Di Carlo developed a trap device to 
capture single HeLa cells and observe how these cells proliferated and divided 
[55]. Kobel and his coworkers designed a microfluidic chip that comprised of 
2048 single-cell traps to study non-adherent stem cells [56]. The trap dimension 
and shape could be easily customized for different assay purposes. For example, 
Lee and Liu designed an array of single-cell traps with 8 μm openings. They 
used this device to study single cell stiffness, mimicking micropipette aspiration, 
but in a high-throughput manner [57]. Voldman’s group has used a U-shaped 
trap to create two-cell pairs and observe lymphocyte interactions at single-cell 
level [58]. 
Hence, hydrodynamic trap is a simple technique to obtain spatially isolated 
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single cells for single-cell long-term culture and other applications. However, 
comprehensive biochemical single-cell assay cannot be achieved using simple 
trap design. This is because cells at neighboring capture sites are still not 
completely isolated from each other. Biomolecules produced from one cell can 
diffuse to neighboring cells in the trap chamber. Consequently, precise 
biochemical assays, such as measuring single-cell secretion and metabolism, is 
difficult to achieve in a hydrodynamic trap system.  
 
Figure 2.5 (A) Device schematics of hydrodynamic trap for single-cell capture 
with an enlarged image showing single cell sitting at the center of a capture site 
[55]. (B) Illustration of operation of microwell-based single-cell device with 
two phase-contrast images showing cells falling in microwell matrix [59]. (C) 
(Above) image of valve-based microchamber device where yellow channels 
control the on-off of the beneath cell channel. (Below) image of a cell trapped 
in the enclosed microchamber [60]. 
 
2.5.2 Microwell 
Microwell devices are similar to the commonly-used 96 well plate but with 
nanoliter well volume. Cells are first seeded on top of the microwell before they 
enter individual wells by gravitational sedimentation or centrifugation. Cells 
that fail to enter microwells are washed away and only single cells falling in the 
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microwells are used for subsequent analysis as shown in figure 2.5(B) [59]. The 
probability of capturing a single cell in microwell depends on the microwell size. 
Rettig and Folch demonstrated the single-cell capture rate of microwell device 
ranged from 92.2% for 20 µm (well diameter) design to 25% for 35 µm design 
using fibroblast cells [59]. High-throughput quantitative analysis on single yeast 
response to mating pheromone was conducted on a microwell device on real-
time and time-lapse basis [61]. Compared with hydrodynamic trap, the 
microwell design provides better spatial confinement for cells. Therefore, 
microwell device has improved assay accuracy and operation reliability. 
Nevertheless, microwell device does not provide a completely isolated 
environment for single cells. Cell solution still flows above the microwell 
structure to provide nutrients and remove metabolic waste for better long-term 
survival. As a result, cells in neighboring wells can still “contaminate” each 
other via diffusion of biomolecules, hindering the acquisition of a pure signal 
from a single cell. In order to improve on the single-cell isolation, a lid 
membrane can be added on top of the microwell device. After cells enter 
microwells, the membrane can be pushed against the microwell layer to close 
every microwell. Wu and her colleagues deployed this design to study 
enzymatic activity of single cancer cells in microwells under drug treatments 
[62]. However, adding the membrane layer could complicate system design and 
operation. Besides, the pressure inside microwells would increase when closing 
the lid membrane. The effect of high pressure on single-cell behaviors is still 
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unknown.   
 
2.5.3 Valve-assisted microchamber technique 
Rather than closing the entire microwells with a large lid, better control can be 
achieved in valve-assisted microchamber system. A microchamber device 
consists of multiple layers of channel structures. Gas control channels lie above 
sample channels with a thin membrane in between of them. By controlling the 
pressure in gas channel, the membrane can be locally deformed to open/close 
the sample channel, similar to the “on/off” function of a switch as shown in 
figure 2.5(C) [60]. Precise fluid control can be achieved with the help of gas 
valves. Therefore, complex biological assays such as single-cell PCR and DNA 
sequencing can be performed using the microchamber system. For example, 
Quake’s group used an integrated microchamber technique to conduct single-
cell gene expression analysis (i.e. RT-PCR analysis) with off-chip 
electrophoresis analysis [63]. A similar design was also used to study gene 
expression of single human embryonic stem cells [64]. Fluidigm, the famous 
microfluidic company founded by Quake, commercialized this valve-assisted 
microchamber to perform single-cell genetic studies. Microchamber systems 
can be scaled up to perform high-throughput single cell genetic expression 
analysis. Hansen’s group developed a microchamber system that could perform 
300 parallel RT-qPCR assays in a run and execute all steps of single-cell capture, 
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lysis, reverse transcription and qPCR [65].  
It is evident that valve-assisted microchamber system is capable of performing 
complex single-cell analysis with precise control of fluid. Despite its advantages, 
the equipment cost is rather high because accurate gas control system is needed. 
Also, this technology is hard to scale up beyond 1000 capture sites because the 
fabrication needs to be extremely precise as the microfluidic device goes beyond 
3-layers PDMS structure.  
 
2.5.4 Droplet technique 
Unlike the first three platforms where cells are captured at fixed trap sites, 
droplet-based system uses oil and aqueous solutions to create floating water-in-
oil emulsions for single-cell isolation. In the microfluidic droplet generator 
(either cross-flow or T-junction), the aqueous solution is pinched by continuous 
oil flow and breaks into small droplets due to Plateau-Rayleigh instability [66]. 
Cell encapsulation can be achieved during droplet generation. The number of 
cells encapsulated in each droplet follows a Poisson distribution, where the key 
determining factors include droplet volume and cell concentration [67]. Cells 
are usually encapsulated with various reagents and/or drugs in order to conduct 
biological assays on the basis of single cells [68]. Comprehensive droplet 
operations, such as droplet generation, merging, mixing, incubation and 




As cell-containing droplets are surrounded by oil solution, biomolecules 
produced by cells are well-confined within droplets and can accumulate to 
relatively high concentrations. Hence, the cross-contamination issue is resolved 
and the detection sensitivity is greatly enhanced. Drug screening, PCR, 
measurement of cytokine production and metabolism as well as selective 
evolution have been successfully achieved using droplet-based platform (figure 
2.6) [70-73]. Recently, several modified forms of droplet technology, such as 
hanging droplet and stationary droplet array, have emerged to improve the 
spatial resolution of individual droplets [74, 75].  
Apart from these advantages, the droplet-based single-cell assay is primarily 
limited by the uncontrolled encapsulation process. Many empty droplets or 
multi-cell droplets (~ 70%) are generated, as modelled by Poisson statics, which 
unavoidably reduces the utility of downstream analysis. Moreover, droplet-
based platform is intrinsically difficult for liquid addition and removal because 
of the droplet integrity. Therefore, antibody-based detection that requires 
addition of secondary antibody and washing is generally hard to be realized 
using the droplet platform. Although pico-injector [76], magnetic-controlled 
droplet manipulation [77] and droplet gelling [78] have been developed to solve 




Figure 2.6 (A) A series of images demonstrating droplet generation, droplet 
merging, droplet mixing, droplet incubation and droplet-based single-cell 
detection for drug screening [69]. (B) Encapsulated cancer cells in droplets 
showing phosphorylation of kinase [70].(C) Encapsulated cells and beads in 
droplets showing active antibody production [73]. 
Overall, microfluidics offers a versatile solution to perform comprehensive 
biological assays at the single-cell level. Compared with macro-scale analytic 
tools, microfluidic single-cell platforms possess many advantages: low device 
cost, small reagent consumption, simple fluid control, easy to scale up, high 
sensitivity and fast reaction rate. So far, various single-cell compartment 
strategies have been developed and customized for different downstream 
applications. The features of the four main microfluidic single-cell techniques 
are summarized in the following table for comparison. 
 











Simple High High High 
Microwell Simple High High High 
Valve-assisted 
microchamber 
Complex Low Low High 
Droplet Simple High Low High 
 
2.6 Selection of droplet as SCA platform to test the hypotheses 
Droplet microfluidics is chosen to perform single-cell functional analysis in this 
PhD project. Firstly, droplet-based platform has low cross-contamination which 
is critical for accurate long-term observations. Secondly, cells in droplets are 
not subjected to any physical stress which guarantees the cell viability and 
reliability of single-cell assay. Droplet microfluidic systems are also fast and 
easy to fabricate due to its one-layer structure. Last but not least, this technology 
can be scaled-up in terms of droplet generation and detection for high 




Chapter 3. Jetting-based droplet microfluidics for high 
single cell encapsulation 
3.1  Introduction 
Based on the literature review in Chapter 2, microfluidic droplet approach has 
been selected to study single cells because of its high-throughput cell 
encapsulation (up to 103 droplets per second), simple fluidic control, high 
detection sensitivity and low contamination across neighbouring droplets [69, 
78]. Despite these advantages, microfluidic droplet system has an intrinsic 
drawback – low single-cell encapsulation rate, limiting the efficiency of 
downstream biological assay. Although some approaches have been proposed 
to enhance the single-cell efficiency, those approaches either require high cell 
concentration or need active droplet sorting based on cell labelling. These 
additional requirements largely restrict the clinical applications of droplet 
technology since clinical samples are usually low in cell abundance and original 
cell status must be preserved. In this chapter, we discuss the novel usage of 
jetting and size-based sorting for passive enhancement of single-cell 
encapsulation efficiency regardless of input cell concentration. We demonstrate 
the downstream application on single-cell protease assay and drug test.  
 
3.1.1 Poisson distribution: limitation on single-cell analysis 
Droplet microfluidics has been extensively applied for single-cell analysis. 
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Continuous cell solution is broken into small droplets by oil sheath flow as 
shown in Figure 3.1(A). Cells randomly suspended in the solution are 
encapsulated into droplets in an uncontrolled manner, which leads to generation 
of undesirable empty droplets. In fact, the probability of number of cells per 
droplet in the random encapsulation process could be predicted by Poisson 
statistics as shown below,  
 𝑃(𝜆; 𝑘) =  
𝜆𝑘 𝑒𝑥𝑝 (−𝜆) 
𝑘!
 (3.1) 
where 𝑃  stands for probability of getting certain type of droplet, 𝑘  is the 
desired number of cells in the droplet and 𝜆 is the average number of cells per 
droplet [67]. The average number of cells per droplet 𝜆 is defined as the total 
number of cells in 1mL of cell solution divided by the total number of droplets 
produced from 1mL cell solution. To estimate the probability of getting single 
cells inside droplets, 𝑘 is set to 1. As a result, the probability depends on the 
𝜆  value, which is predominantly determined by the concentration of cell 
solution and the droplet volume.  
Based on the formula, the theoretical maximum single-cell rate is around 36% 
when 𝜆 is equal to 1. That is to say, the number of cells in solution need to 
match with the number of droplets generated from the solution in order to reach 
the optimal single-cell encapsulation rate. For example, when 1 million cells in 
1mL solution are encapsulated into 1 million droplets (e.g. 1nL per droplet), the 
single-cell encapsulation rate reaches maximum value in theory. 
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For most microfluidic droplet platforms, the droplet size is in the range of 10 to 
100 μm in diameter, corresponding to 0.5 picoliter to 0.5 nanoliter in volume. 
The cell concentration has to be more than one million of cells per milliliter in 
order to achieve above 30% single-cell encapsulation efficiency, which is 
practically difficult for most of cell samples. Therefore, the realistic single-cell 
encapsulation efficiency is generally lower than the optimal efficiency, 
especially under low cell concentration condition as demonstrated in Table 3-1 
and Figure 3.1(B). 
 
Table 3-1. The predicted cell encapsulation percentage under different cell 
concentrations and droplet sizes based on the Poisson distribution  
Cell 
Concentration 
25 µm droplet  50 µm droplet 
0 cell 1 cell  1+ cell 0 cell 1 cell  1+ cell 
20 k cells per mL 99.98% 0.02% 0.00% 99.87% 0.13% 0.00% 
200 k cells per mL 99.84% 0.16% 0.00% 98.70% 1.29% 0.01% 
2 M cells per mL 98.38% 1.61% 0.01% 87.73% 11.48% 0.79% 
20 M cells per mL 84.91% 13.89% 1.20% 27.01% 35.35% 37.64% 
 
3.1.2 State-of-the-art for enhancement of single-cell encapsulation 
High encapsulation rate enables effective detection of single cells in 
downstream biological assays. Different microfluidic approaches have been 
developed to overcome the Poisson limitation encountered in the random 
encapsulation process. These approaches can be classified into three categories 
based on the enhancement principle, including inertial cell ordering, active 
droplet selection and hydrodynamic droplet sorting.  
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Inertial cell ordering can be deployed before droplet formation in order to 
improve single-cell encapsulation efficiency. Cells can be ordered along the 
microchannel under sufficiently high flow rates to form an equally spaced “cell 
train” due to the net effect of inertial force and wall lift force [79]. Droplet 
generation frequency can be synchronized with the distance between cells so 
that the cell train can be broken into uniform droplets with single cells inside as 
shown in Figure 3.1(C). The single-cell encapsulation efficiency has been 
improved to 80% by coupling a straight (~5 cm) or spiral channel (~1 cm) with 
a droplet generator [79, 80]. The original status of cells can be retained when 
using this approach because fluorescent labelling is unnecessary. However, 
inertial ordering method requires extremely high cell densities (106 ~107 
cells/mL) to prevent the generation of empty space in the cell train, which 
deteriorates the cell encapsulation efficiency [70, 81]. This requirement on cell 
concentration largely limits the single-cell assay application on samples with 
low cell abundance.  
The active droplet selection approach is another way to improve single-cell 
encapsulation efficiency. The system consists of two critical elements: a 
detector to detect presence of single cells in droplets based on fluorescence 
labelling, and a sorter to manipulate droplets relying on external force or field. 
Many microfluidic sorting techniques have been successfully applied on droplet 
application, such as gas-controlled valve [82], dielectrophoresis (DEP) force 
[83], and surface acoustic wave (SAW) [84]. Ideally, single-cell encapsulation 
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efficiency can be enhanced to 100% using active selection method, by removing 
all empty droplets as shown in Figure 3.1(D). However, fluorescent labelling, 
which is essential to distinguish empty and cell-containing droplets, might alter 
the cell function, leading to incorrect cell assay results [85, 86]. More recently, 
image processing method has been developed to detect cells inside droplet 
without the aid of fluorescent labelling [87]. Nevertheless, this method is 
computationally expensive at current stage as thousands of images captured by 
high speed camera must be analysed in a short time frame. Therefore, the 
processing throughput is limited to 10Hz. Apart from these drawbacks, active 
droplet selection system is usually expensive to construct due to optical 
components and control systems.  
Moreover, hydrodynamic droplet sorting has been demonstrated to improve 
single-cell encapsulation rate by separating droplets of different sizes when 
input cell concentration is high (~107 cells/mL). Passive droplet sorting was 
applied in single-cell study with achieving above 60% single cell ratio [88]. 
However, hydrodynamic sorting, such as pinch flow fractionation (PFF), is not 
a favourable method to sort water droplets in oil environment. This is because 
flow control in viscous oil is much more difficult than in normal aqueous fluid, 
imposing challenges on experiment operation and sorting accuracy. 
All three techniques do not provide a comprehensive solution for single-cell 
encapsulation enhancement. Hence, in order to effectively study single cells 
using droplet microfluidics for rapid screening, new integrated method, which 
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takes low cell centration and avoidance of labelling into consideration, is 
required.    
 
Figure 3.1 (A) Image of a flow-focusing droplet generator producing cell 
encapsulated droplets. The white arrows point to the cells inside droplets. Many 
of droplets remain empty [67]. (B) Comparison between experimental results 
(dotted lines with open dot) and theoretical model of Poisson distribution (solid 
lines with filled dot) shows a good agreement. 60% to 90% of droplets are empty. 
Inset showing hundreds of droplets with 3 droplets containing single cells [67]. 
(C) Above good single-cell encapsulation achieved by cell ordering. Below 
image of the droplet generator where cells are first ordered in a long straight 
channel to form an equally spaced “cell train” [79]. (D) Dielectrophoresis 
(DEP)-based droplet active sorting where the presence of cell is detected by 
fluorescent signal and the droplets are manipulated by positive DEP force [83]. 
 
3.1.3 Proposed techniques and hypothesis 
Here, a novel droplet technique is proposed to take into account the low cell 
concentration and avoidance of fluorescent labelling by applying passive size-
based droplet sorting. The microfluidic platform comprises a droplet jetting 
generator and a deterministic lateral displacement (DLD) size-sorting channel 
[89, 90]. Jetting creates size difference between cell-encapsulated and empty 
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droplets. Subsequently, DLD performs size-based sorting to isolate large cell-
encapsulated droplets from small empty droplets in a robust and passive 
manner. We hypothesize that integration of droplet jetting and DLD sorting can 
increase single-cell encapsulation rate regardless of input cell concentration. By 
implementing the proposed technique, we are able to perform effective single-
cell functional assay on samples with low cell abundance. We also hypothesize 
that protease secreted from single cancer cells can be assayed in individual 
droplets as protease concentration is accumulated to a rather high level in a 
picoliter droplet. From this, we will further study the heterogeneity of matrix 
metalloproteinase (MMP) secretion by cancer cells under normal and drug 
treated condition using the proposed platform in order to provide more 
understanding in cancer biology and disease management.   
 
3.2  Material and Methods 
3.2.1 Device design  
The microfluidic device consisted of a flow-focusing droplet generator and a 
size-based droplet sorting array based on deterministic lateral displacement 
principle. In the flow-focusing droplet generator, the width of oil, cell solution 
and droplet channels was set 150 µm, 70 µm and 100 µm, respectively, as shown 
in Figure 3.2(A). The reason of having narrow channel for cell solution was to 
prevent oil backflow at high flow rate. For downstream matrix 
metalloproteinase (MMP) activity assay, a Y-shape junction was incorporated 
39 
 
into the droplet generator to mix the reagent with cell solution prior to 
encapsulation. As oil flowed into the junction point, it sheared aqueous solution 
(cell solution) from both sides to form water-in-oil droplets in a continuous 
manner. Size difference between cell-encapsulated droplets and empty droplets 
could be created by intentionally reducing the droplet size smaller than the 
average size of a cell.  
Once droplets were generated, they flowed into a size-based sorter to separate 
the large cell-containing droplets from the small empty droplets. The sorter was 
essentially a DLD array of micropillars. When large droplets entered the sorting 
section, they collided with micropillar at every lateral position of the array and 
were gradually deflected to one side of the channel from the centre position 
while moving towards the outlet. In contrast, small droplets maintained their 
original moving trajectory without any lateral deflection while moving towards 
the channel end [90]. In this way, the droplets could be successfully separated 
at the bifurcation point of outlets, as shown in Figure 3.2(B).  
Based on the principle of DLD design, the critical dimension of separation could 
be adjusted by tuning the micropillar diameter, gap and row shift distance. In 
order to separate large cell-containing droplets (~25 µm) and small empty 
droplets (<15 µm), the micropillar diameter was set 50 µm, the gap between 
micropillars was set 50 µm and the row shift distance was set 10 µm. The 
bifurcation point at the end of the sorting section was set 400 µm away from the 
left channel wall and 1600 µm away from the right channel wall, which led one 
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fifth of fluid to enter the cell-droplet outlet and the rest of fluid to enter the waste 
outlet. The width of the entire sorting section was set 2 mm in order to have 
good lateral resolution. The length of the sorting section was set 12 mm to 
guarantee large droplets can be sufficiently deflected to the cell-droplet outlet.  
 
Figure 3.2 (A) Schematics of the microfluidic device for high single-cell 
encapsulation rate. The microfluidic design consists of a cross-flow droplet 
generator with a deterministic lateral displacement (DLD) micropillar array. (B) 
Illustration of the device operation. Cell solution is firstly mixed with reagent 
and then compartmentalized into small droplets at the jetting region. Cell-
containing droplets appear bigger than empty droplets and can be deflected 
toward channel side wall in the DLD sorting channel.  
 
3.2.2 Microfluidic device fabrication 
The channel layouts were first designed using AutoCAD student version 
(AutoDesk, USA). After finishing, the design was sent to a mask shop (Infinite 
Graphics, Singapore) for mask fabrication. Then the microfluidic device was 
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created in Polydimethylsiloxane (PDMS) (Dow Corning, USA) using standard 
soft lithography method [91]. In brief, a 4-inch silicon wafer (Latech, Singapore) 
was first fabricated to produce a master mold based on the mask design using 
deep reactive ion etching (DRIE). The reason of choosing DRIE mold rather 
than simple SU-8 mold is to ensure good size and height uniformity of the 
micropillar pattern in the droplet separation array. The trenches were etched 50 
µm in depth into the silicon wafer, which was essentially the microfluidic 
channel height. After etching, the silicon master wafer was silanized with 
trichloro (1H, 1H, 2H, 2H-perfluorooctyl) silane (Sigma Aldrich, USA) for 1 
hour to prevent PDMS from sticking onto the silicon wafer surface. PDMS 
prepolymer mixed in 10:1 (w/w) ratio with curing agent was casted over the 
master mold to replicate the reverse pattern. After degassing in a vacuum 
desiccator for an hour, the PDMS was cured at 70 °C oven for 2 hours. The 
cured PDMS was cut out using surgical scalpel and peeled off from the master 
wafer. Inlet and outlet ports were produced using a 1.20 mm Harris Uni-Core 
puncher (Ted Pella, USA). After cleaning with isopropyl alcohol (IPA) (Sigma 
Aldrich, USA) and Scotch tape (3M, USA), the PDMS devices were irreversibly 
bonded to a PDMS-coated microscopic glass slide (Corning, USA) using an 
oxygen plasma machine (Femto Science, Korea). The hydrophobic channel 
surfaces are necessary to prevent aqueous solution from sticking to the channel 
wall. The PDMS-coated glass slides were produced by spin-coating a mixture 
of PDMS and hexane (Sigma Aldrich, USA) with a 1:1 (w/w) ratio at 1500 rpm. 
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After plasma bonding, the device was kept in the 70 °C oven overnight, forming 
strong bonding at interface as well as restoring PDMS surface hydrophobicity. 
3.2.3 Cell culture 
Human non-small lung cancer cell line PC-9 was a kind gift from Dr Daniel at 
National University Hospital. PC-9 cells were used to determine the single-cell 
encapsulation ratio and enzymatic activities at single-cell level. PC-9 cells were 
cultured in RPMI-1640 medium (ThermoFisher Scientific, Singapore) 
supplemented with 10% (v/v) fetal bovine serum (FBS) (Life technologies, 
Singapore) and 1% (v/v) penicillin-streptomycin (Life technologies, 
Singapore). The incubation environment was maintained at 37 °C in a 
humidified atmosphere with 5% CO2. The cells were split every 3 days using 
2x Trypsin-EDTA (Life technologies, Singapore) under sterile conditions. 
Green fluorescent calcein-AM live stain (Life technologies, Singapore) was 
used for cell viability evaluation and cell visualization in droplets.  
Drug doxycycline (Sigma Aldrich, USA) was used in protease inhibition 
experiment [92]. Viable PC-9 cells were firstly harvested using trypsin and then 
re-suspended in fresh culture medium with 20 µg/mL doxycycline [93]. After 
3-hour incubation in the 37 °C, treated PC-9 cells were loaded into a syringe for 
droplet-based single cell protease assay. 
3.2.4 Droplet generation 
Monodispersed water-in-oil emulsion was generated by jetting at a flow-
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focusing junction. Aqueous fluids and mineral oil (M-oil, Sigma Aldrich, USA) 
were first loaded into separate plastic syringes (Terumo, Japan) and then 
introduced into the device using syringe pumps (Harvard Apparatus, USA). The 
microfluidic device and syringes were connected using micro polyethylene 
tubing (Scientific Commodities, USA) (0.38 mm inner diameter x 1.09 mm 
outer diameter). Non-ionic surfactants 3% (v/v) Span 80 (Sigma Aldrich, USA) 
and 2% (v/v) Abil EM90 (Evonik, Germany) was added into mineral oil to 
stabilize jetting formation and prevent droplet coalescence. In the cell 
experiment, biocompatible density gradient medium OptiPrep (Sigma Aldrich, 
USA) was mixed with cell solution (volume ratio 16:84) to minimize the effect 
of cell sedimentation. 
3.2.5 Matrix Metalloproteinase Assay 
A fluorescent resonance energy transfer (FRET)-based polypeptide matrix 
metalloproteinase (MMP) substrate (Biozyme Inc, USA) was used to measure 
the enzymatic activity of single cancer cells. The substrate basically consists of 
a fluorophore and a quencher. Both of them are connected by a polypeptide 
chain. The secreted MMPs from cancer cells could cleave the polypeptide and 
release fluorophores from quenchers, causing increase of droplet fluorescence 
signal. The MMP substrate solution was diluted to 40 µM concentration in 50 
mM Tris buffer (pH 7.5, containing 150 mM NaCl, 2 mM CaCl2, 5 μM ZnSO4, 
and 0.01% Brij-35) (Sigma Aldrich, USA) before it was loaded into syringe. 
The final concentration of MMP substrate in each droplet was 20 µM after 1:1 
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dilution with cell solution at the Y-junction inlet. Before assaying cancer cells, 
pure MMP enzyme (Enzo Life Sciences, USA) was used to calibrate the droplet 
system. One thing to notice is that the MMP substrate used in the experiment is 
not specific to one kind of MMPs. It is especially sensitive to MMP-9 and 
MMP-13.  
3.2.6 Optical Setup 
The microfluidic devices were mounted on an inverted microscope (Nikon 
Eclipse Ti, Japan) for experiments. The process of droplet formation and sorting 
was observed and recorded using a high-speed camera (Phantom v7.3, USA). A 
fluorescence illumination microscopy system (CoolLED, UK) and digital 
CMOS camera (Hamamastu Orca Flash 4, Japan) were used to measure the 
single-cell encapsulation rate with fluorescence-labeled cells and perform 
automatic time lapse illumination for the single-cell assay experiment. The 
resulting fluorescent signals were analyzed using Image J® software (National 
Institutes of Health, USA). 
 
3.3  Results and Discussion 
3.3.1 Droplet generation using jetting and oil selection 
When an aqueous phase fluid is shorn by an immiscible oil phase from both 
sides, it can be broken into droplets to form water-in-oil emulsions via two 
different mechanisms: dripping and jetting [89]. Under the dripping condition, 
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the aqueous phase is broken into droplets near the orifice due to pinch effect of 
the oil phase to form monodispersed emulsions. In this case, size of droplets is 
usually similar to or even larger than the microchannel dimension. By contrast, 
under the jetting condition, the aqueous phase extends a thin tip into the oil 
phase due to strong shearing effect of the oil phase. The thin tip eventually 
breaks into droplets away from the orifice because of Rayleigh-Plateau 
instability [94]. Under jetting, size of droplets is usually much smaller than the 
microchannel dimension. Hence, it is possible to produce uniform small 
droplets in a relatively large channel under jetting. Moreover, under jetting 
regime, droplet size can be precisely adjusted by controlling the flow rate of 
aqueous and oil solution.  
Based on these droplet generation mechanisms, two designs were proposed to 
make droplets smaller than a cell size so that size difference can be created 
between empty droplets and cell-containing droplets. The first design was to 
reduce the dimension of droplet formation channel to 10 μm and then generate 
droplets using drippling. In this design, the channel was susceptible to clogging 
caused by cell clusters and PDMS debris. The second design was to keep 
channel dimension large and then use viscous oil to shear aqueous solution to 
form jetting. Compared with the first design, the second design is more resistant 
to channel clogging during the cell encapsulation process. Therefore, jetting is 
chosen to produce droplets in this project.  
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Previous studies have characterized the factors that determine either jetting or 
dripping to happen. They are the capillary number of the outer fluid and Weber 
number of the inner fluid. Their equations are shown as 
 𝐶𝑜𝑢𝑡 = 𝜂𝑜𝑢𝑡𝑢𝑜𝑢𝑡/ 𝛾 (3.2) 
 𝑊𝑖𝑛 = 𝜌𝑖𝑛𝐷𝑜𝑟𝑖𝑓𝑖𝑐𝑒𝑢𝑖𝑛
2 /𝛾 (3.3) 
where 𝜂𝑜𝑢𝑡  is the viscosity of outer fluid, 𝑢𝑜𝑢𝑡  and 𝑢𝑖𝑛 are the mean 
velocities of outer and inner fluid respectively, 𝛾 is the surface tension, 𝜌𝑖𝑛 is 
the density of inner fluid and 𝐷𝑜𝑟𝑖𝑓𝑖𝑐𝑒is the dimension of orifice. Only when the 
sum of 𝐶𝑜𝑢𝑡 and 𝑊𝑖𝑛 is larger than one order of magnitude will jetting occur 
[95]. Otherwise, dripping with large droplet formation or continuous stream 
without droplet formation will occur.  
High viscosity of outer oil and small surface tension is important for jetting 
formation. Eventually, mineral oil was selected because of its high viscosity 
(25.3 mPa·s). The viscosity of water is about 1mPa·s. Other oil candidates, such 
as hexadecane, fluorocarbon oil and silicon oil, are either too smooth to produce 
jetting or too viscous to be injected using syringe pump. 
 
3.3.2 Selection of surfactants to prevent coalescence 
Surfactants are compounds that lower the surface tension between two liquids. 
Surfactants are amphiphilic compounds, containing both hydrophobic groups 
(tails) and hydrophilic groups (heads). They can aggregate at oil-water interface 
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and promote the overall stability of bi-phase system. Surfactants are essential to 
droplet microfluidics because they prevent droplet coalescence. Without proper 
surfactant, water-in-oil droplets tend to merge with each other to minimize the 
overall system energy. 
Surfactants can be divided into non-ionic, anionic, cationic and amphoteric 
groups based on the charge carried by hydrophilic heads. Ionic (anionic, cationic 
and amphoteric) surfactants can denature protein and lyse cells. As the water-
in-oil droplets were used to encapsulate cancer cells and study protease 
activities, only non-ionic surfactants can be applied in our droplet system [96]. 
In literature, SPAN 80 and Abil EM90 are common non-ionic surfactants for 
mineral oil [96, 97]. To determine which surfactant to use, we investigated the 
effect of coalescence prevention and jetting stability of both surfactants. In the 
coalescence experiment, 5% SPAN 80 in mineral oil failed to prevent droplet 
from merging at stationary condition for 1 hour. Although 5% Abil EM90 
provided a better droplet stability, it changed the surface tension between water 
and oil phase dramatically. As a result, jetting could no longer be formed.  
Neither pure SPAN 80 nor Abil EM90 worked well with mineral oil. The 
mixture of SPAN 80 and Abil EM90 with mineral oil was utilized to leverage 
their advantages and compensate their disadvantages. Eventually, the 
combination of 3% SPAN 80 and 2% Abil EM90 demonstrated both good 
droplet and jetting stability and was used in the following experiment. 
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3.3.3 Droplet size characterization under different flow rate 
Once jetting was established in the droplet generator, we started to investigate 
the relationship between flow rate and droplet size. Varied flow rates of oil and 
aqueous solutions were applied to form droplets of different sizes. The size of 
the droplets could be controlled within a range of 10 to 40 μm in diameter inside 
a 100-μm-wide flow-focusing channel. The measurement results revealed that 
the droplet size was linearly proportional to (Qaqueous /Qoil)
0.5, as shown in Figure 
3.3, where Qaqueous and Qoil are the flow rates of the aqueous and oil solutions, 
respectively. When the ratio of Qaqueous to Qoil was reduced by decreasing the 
aqueous flow rate or increasing the oil flow rate, the size of the droplets reduced 
correspondingly. When this flow ratio was greater than 0.4, the jetting tip 
became a thin stream and no more droplets could be generated. 
Based on the characterized relationship, the optimal flow rates to produce size 
distinction between empty droplets and cell-containing droplets were 0.5 
μL/min for the cell solution and 20 μL/min for the oil solution. The resulting 
diameter of empty droplets was 14.4 ±  0.7 μm (with relative standard 
deviation of 4.9%). The average size of cultured PC-9 cancer cells was 15.6 μm. 
When a cancer cell was encapsulated into a droplet, the droplet size could 
expand to 25 μm as shown in Figure 3.4(A). In this way, 10 μm size difference 
between empty and cell-containing droplet was created for downstream size-




Figure 3.3 (A) Brightfield images of droplet jetting under various flow 
conditions. Above: oil flow rate 20μL/min, water flow rate 0.25 μL/min; Middle: 
oil flow rate 20μL/min, water flow rate 0.5 μL/min; Lower: oil flow rate 
20μL/min, water flow rate 1 μL/min. The droplet size clearly increases as the 
water flow rate increases. (B) Quantified relationship between flow rate ratio 
and droplet size with a fitting model. The experimental results show a good 




3.3.4 Characterization of DLD based droplet separation 
A deterministic lateral displacement (DLD) micropillar array was connected to 
the droplet jetting generator to sort the large droplets containing encapsulated 
cells from the small empty droplets for effective downstream single-cell 
measurement. There were two reasons to deploy DLD rather than other 
microfluidic separation methods to perform droplet sorting. Firstly, the 
separation principle of DLD design relies heavily on the geometric layout of 
micropillars, rather than fluidic conditions (such as Reynolds number). Hence, 
it can be easily adopted to any oil-ambient applications (such as water-in-oil 
droplet separation) [98]. Whereas, inertial microfluidic separation, one of the 
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most commonly-used particle separation approaches, can hardly work in the 
viscous oil environment due to limited Reynold’s number. Most of inertial 
microfluidics requires a high flow rate to reach 50 ~ 100 Reynold’s number [99]. 
Viscous oil effectively decreases the Reynold’s number compared to water 
solution at the same flow rate, thus hindering the inertial based particle 
separation. Secondly, the DLD separation is independent of flow rate. 
Microfluidic droplet generation, in general, operates at low flow rate, ranging 
from 0.1 to 10 μL/min. This slow rate makes droplet generation incompatible 
to most of inertial microfluidic approach. However, DLD is able to achieve 
separation at such a low flow rate, and thus can be easily integrated to droplet 
generator to perform sorting directly.  
Based on the aforementioned droplet size difference, the critical dimension of 





where D is the micropillar diameter, 50 μm; G is the micropillar gap, 50 μm; d 
is the row shift distance, 10 μm; and η is a parabolic flow correction factor 
equal to 2, as shown in Figure 3.2(B) [100]. The optimized pillar diameter and 
gap design reduced the chance of droplet breakage when the droplets collided 
with pillars and passed through the gaps during the sorting process. The small 
empty droplets whose diameters were below the critical dimension of the DLD 
separation followed their original flowing direction inside the micropillar array, 
heading to the waste outlet. The droplets containing cells, whose diameters were 
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above the critical dimension, were deflected from their original direction toward 
the upper side wall and eventually entered an observation chamber as shown in 
Figure 3.4. 
 
Figure 3.4 (A) A series of images showing the cell encapsulation process under 
jetting condition. Scale bar = 30 μm. (B) Image showing a cell-containing 
droplet gradually migrates away from the main stream of empty droplets. Scale 
bar = 60 μm (C) Image showing a cell-containing droplet is separated from other 
empty droplets and heading to observation chamber. Scale bar = 150 μm (D) 
Images of cell-containing droplets and empty droplets in the observation 
chamber. 
 
3.3.5 Characterization of single-cell rate enhancement  
In order to characterize the actual single-cell encapsulation rate of the 
combination of jetting and DLD sorting, freshly harvested cancer cells were first 
labelled using green fluorescent calcein-AM live stain and then injected into the 
developed device. Based on both bright-field and fluorescent images observed 
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under a fluorescence microscope (Figure 3.5(A) and 3.5(B)), the number of cells 
in individual droplets could be recorded to calculate the cell encapsulation rate.  
Four different cell concentrations (2×104, 2×105, 2×106, and 2×107 cells/mL) 
were tested to prove that the integrated droplet device can overcome the Poisson 
limitation in terms of single-cell encapsulation rate at various cell 
concentrations. The experiment results revealed that high single-cell 
encapsulation efficiencies were obtained regardless of the cell concentrations in 
the sample solutions, yielding much better performance than that predicted by 
the Poisson model as illustrated in Figure 3.5(C). For instance, the single-cell 
rate of the random encapsulation process was as low as 0.02% for the cell 
solution with a concentration of 2×104/mL, whereas the developed device could 
achieve a single-cell rate of ~65%. When the cell concentration increased to 
2×107/mL, the single-cell rate of the random encapsulation was approximately 
13.9%, but still far below the enhanced rate of 70% achieved by the developed 
device. Therefore, a significant improvement in cell encapsulation rates was 
observed, particularly under low cell concentrations. 
The single-cell encapsulation efficiency reached its maximum at 78% when the 
input cell concentration was 2×106 /mL. A slight decrease in the single-cell 
encapsulation rate was observed at both lower and higher cell concentrations, 
which might be due to empty droplets formed under flow fluctuations and multi-
cell containing droplets generated from cell clusters formed during sample 
preparation. Further improvements in single-cell encapsulation performance 
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might be achieved by reducing the empty droplet size further to counter the 
effect of flow fluctuation and adding another DLD section to remove multi-cell 
containing droplets that are larger than 30 μm.  
Additionally, we also characterized the false negative sorting rate, referring to 
the ratio of the cell-containing droplets entering the waste outlet, by monitoring 
fluorescent signals carried by cells at the bifurcation point. Only 2 out of 231 
(~0.9%) cell-containing droplets entered the empty droplet outlet by mistake, 
corresponding to 0.9% false negative sorting rate. Small cells and cell debris 
could contribute to this false negative results. 
 
Figure 3.5 (A) A bright-field image of cell-containing droplets and (B) the 
corresponding fluorescent image showing 13 of 17 droplets (highlighted with 
black-dashed cycles in the bright-field image) with single cell inside. (C) The 
cell encapsulation efficiency was measured for different input cell 
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concentrations. Due to the usage of size-based sorting, high single-cell 
encapsulation efficiency (~70%) was achieved regardless of varied cell 
concentrations. Sample size = 537 droplets. (D) The survival rate of PC-9 cells 
inside droplets was measured for up to 1.5 hours. Sample size = 285 cells.  
 
3.3.6 Viability test of cell in droplets 
A cell viability test was also performed to characterize the cell survival rates 
inside the water droplets over time. All cancer cells were first stained with 
live/dead (Calcein AM @ 1µM / Ethidium homodimer-1 @ 2µM) stain reagent 
and then injected in the integrated device to produce cell-encapsulated droplets. 
The viability of cancer cells was evaluated every half an hour by counting the 
number of viable and dead cells acquired by fluorescence microscopy. 
Sometimes, a small group of cells displayed both live and dead fluorescent 
signals. These double positive cells were considered dead. This is because the 
live stain used here is to detect esterase within a cell, which might not be 
absolutely accurate. Some cells that were undergoing apoptosis may still have 
esterase accumulated and generate false “live” signal.  
The overall viability ratios at different time points are reported in Figure 3.5(D). 
It gradually decreased from 98% to 85% over 1.5 hours due to shortage of 
nutrients and accumulation of metabolites. This result matched with previously 
reported cell viability in droplets of similar size [67]. In our system, the viability 
was approximately 90% after 1 hour of cell encapsulation. Therefore, the 
duration of the subsequent single-cell matrix metalloproteinase (MMP) assay 
experiments was controlled within 1 hour to minimize the false enzymatic 
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signal generated by unhealthy and dead cells. 
3.3.7 Recombinant MMP test 
Before conducting single cancer cell MMP assays, recombinant MMP-9 
enzyme at various concentrations was first tested with the FRET-based 
polypeptide MMP substrate to correlate the MMP concentrations with the 
fluorescence signal read-out. The reasons to choose MMP-9 among the entire 
MMP group to do this calibration included: 1) MMP-9 has been proved a key 
enzyme produced by cancer cells to degrade ECM and promote tumor invasion; 
2) the MMP substrate was sensitive to MMP-9 detection.  
The flow rates of MMP with substrate solution and oil solution were set to 1 
and 20 μL/min, respectively, to produce 20 μm droplets that were similar in size 
to cell-containing droplets. Each droplet contained 20 μM MMP substrate and 
a different concentration of MMP-9 (from 5 to 64 nM). The fluorescence 
intensity of these droplets was captured every 5 minute over 40 minutes as 
shown in Figure 3.6(A). Based on the increase in the fluorescent signal within 
the linear region, the corresponding reaction rate at various enzyme 
concentrations was obtained in units of a.u./min.  
We observed very small fluorescence changes (~25 a.u.) over 40 minutes for 
the negative-control samples, which only contained MMP substrate without 
MMP-9. A linear increase in the reaction rate with increasing MMP 
concentration was observed (Figure 3.6 (B)). Notably, instead of total amount 
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of MMP, only a small fraction of pure recombinant MMP can actively cleave 
MMP substrate. The ratio of active enzyme in the pure MMP sample was 
estimated according to the PrAMA method, as described in the previous work 
[101]. After calibrating the fluorescence intensity of the droplets, the kinetic 
constant Kcat/Km of 6.02×10
4 M-1s-1 was calculated by assuming Michaelis-
Menten kinetics, consistent with previous study of the protease activity of the 
same type of MMP [102]. The kinetic constant Kcat/Km was calculated using the 
following equation: 
 𝑉0 = 𝑆0 × 𝐾𝑐𝑎𝑡/𝐾𝑚 × 𝐸 (3.5) 
where 𝑉0 is the initial reaction rate normalized to the trypsin positive 
control,  𝑆0  is the substrate concentration and 𝐸  is the active MMP 
concentration, which is equal to the product of the MMP concentration and the 
active enzyme ratio (5%). 
 
Figure 3.6 (A) The fluorescence intensity profiles of individual droplet groups 
containing various MMP concentrations (each droplet contained a certain 
concentration of pure MMP-9 and MMP substrate). Sample size = 97 droplets 
(B) The relationship between the reaction rate and MMP concentration in the 





3.3.8 Single-cell assay on protease secretion 
After characterizing pure MMP recombinants, MMPs secreted from individual 
cancer cells were characterized by encapsulating the MMP substrate with cell 
solution into droplets. The secreted MMPs cleaved the substrate polypeptide to 
generate fluorescent signal that sigmoidally increased in intensity with reaction 
time, as shown in Figure 3.7. The fluorescence intensity increased at a slow rate 
in the beginning of the MMP assays and grew fast after some time, because the 
amount of MMPs accumulated gradually with the slow secretion process. The 
fluorescent signals eventually saturated at ~35 minutes due to the MMP 
substrate depletion. Based on the measured fluorescent intensities, cancer cell 
heterogeneity in the MMP activities could clearly be observed, with an increase 
in intensity from 400 to 800 a.u. (with mean value of 544.47 a.u. and standard 
deviation of 132.84 a.u.) over 35 minutes.  
Based on the results obtained from pure MMP characterization, fluorescent 
signals from single cancer cells could be converted to MMP concentration. To 
do that, we only considered the fluorescent rate increase during the first 10 
minutes, assuming a linear increase in the fluorescent signal during this time 
frame. For instance, the minimum and maximum fluorescent signal increasing 
rate of untreated PC-9 cells were 9.5 a.u./min and 20.3 a.u./min, respectively. 
The increasing rate of single-cell signals were then compared with the reaction 
rate that was determined from the pure MMP calibration. Based on the pure 
MMP calibration, these rates correspond to enzyme concentrations of 
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approximately 30 nM and 60 nM. Therefore, the range of ~1.5 to 3 nM active 
MMPs were secreted from individual live cancer cells in 35 minutes by assume 
5% active enzyme ratio.  
Notably, to ensure the consistency of the fluorescent-based assay, the time gap 
between droplet generation and start of assay was strictly controlled. The time 
period for a cell to travel from the reagent mixing area to the observation chip 
was about 30 seconds, and the time required to fill the observation chip was 
about 2 minutes; the summation of these durations was much shorter than the 
saturation time of fluorescent signal increase. Therefore, the readout time points 
for each cell-containing droplet were approximately the same, and the slopes of 
the fluorescence increases could be used to represent the MMP activities.  
The inhibition of the MMP activities of individual cancer cells in response to 
the treatment with doxycycline was then analysed. The developed microfluidic 
device enabled continuous monitoring of the effects of doxycycline on 
individual cancer cells up to 1 hour. Different levels of suppression of MMP 
activities at the same dose of doxycycline were recorded, revealing 
heterogeneity in the resistance of cancer cells against doxycycline. In general, 
the MMP activities were greatly suppressed by doxycycline, as evidenced by 
the reduction in the increase in fluorescence exhibited by the droplet to 100 a.u. 
(with mean value of 81.29 a.u. and standard deviation of 46.06 a.u.) over 35 
minutes (Figure 3.7(B)-red points). The MMP inhibitory effect observed in the 
single-cell droplets system was greater than that in conventional plate reader 
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assay where a batch of cancer cells were assay together in a 96-well plate. In 
the plate reader assay, the MMP activity of PC-9 cancer cells was reduced about 
50% upon doxycycline treatment. However, the MMP activity of the same cell 
line was reduced more than 80% in the droplet-based single cell system. One 
possible explanation was that when in group, cancer cells might secrete 
cytokines and other biomolecules in order to support each other and enhance 
the drug resistance overall.   
After signal conversion, the concentration of active MMPs secreted by 
individual doxycycline-treated cancer cells was reduced to a range of 0.2 to 0.5 
nM. However, a few individual cancer cells retained some level of MMP 
activities under doxycycline treatment, which might suggest that a small group 
of cancer cells could quickly develop doxycycline resistance, even in the 
clonally cultured cancer cell line. 
 
Figure 3.7 (A) Images of untreated and doxycycline-treated single cancer cells 
inside droplets, displaying suppressed MMP activity under the drug effect. (B) 
Quantified fluorescent signals from 9 untreated and 9 doxycycline-treated 
cancer cells, demonstrating the heterogeneity in MMP activities among cancer 
cells and the MMP inhibitory effect of doxycycline. Scattered points: original 
data points; box plots: mean, medium, standard deviation, minimum and 
maximum values. The signal of untreated PC-9 cells was 544.47 ± 132.84 a.u. 
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and the signal of treated PC-9 cells was 81.29 ± 46.06 a.u. after 35-minute 
incubation. The sample size was 18 cells (9 untreated, 9 treated PC-9 cells). 
 
3.4  Conclusions 
An integrated microfluidic device combining a droplet jetting component and a 
DLD sorting channel was developed for effective single-cell encapsulation, 
enabling assays of cell-secreted MMPs using minute quantities of reagents. The 
single-cell encapsulation rate was increased to 78% at an input cell 
concentration of 106 cells/mL, in contrast to the 1.6% rate predicted by the 
Poisson statistics. Single cancer cell protease assays were performed by 
measuring MMP secretion from the individual PC-9 cancer cells inside droplets. 
Heterogeneous MMP activities and various levels of drug resistance were 
observed at the single-cell level. The concentration of MMPs secreted from 
individual cells was in the range of 1.5 to 3 nM. After doxycycline treatment, 
the concentration of MMPs secreted by individual cells was suppressed to 
within 0.2 to 0.5 nM. We believe that our hybrid microfluidic system is ideal 
for the analysis of enzymatic activity at the single-cell level in samples with low 
cell concentrations (e.g. 104 cells/mL), because our method eliminates the need 
for immune-staining and active sorting. With further development on long-term 
stability and droplet size uniformity, this platform can be used for direct 
functional analysis of clinical samples with low cell concentrations for rapid 





Chapter 4. Single cancer cell protease assay using droplet 
platform 
4.1  Introduction 
After developing the integrated droplet device to enhance single-cell 
encapsulation efficiency described in Chapter 3, we would like to conduct a 
comprehensive functional study on both cultured cancer cell lines and patient-
derived circulating tumor cells (CTCs). As invasive cancer cells produce lots of 
matrix metalloproteinases (MMPs), especially MMP-2 and MMP-9, to degrade 
the extracellular matrix (ECM) and gain the ability to migrate, the activity level 
of matrix metalloproteinase has become a potential biomarker to evaluate the 
invasiveness of cancer cells [103, 104]. The MMP activity profiles at single-cell 
level can be utilized to search for aggressive cell subpopulation among a 
heterogeneous ensemble. Furthermore, single-cell proteolytic assay on patient-
derived cancer cells sheds lights on the patients’ disease status and can be further 
leveraged for customized treatment. In this chapter, we will explore how to use 
the droplet microfluidics to study matrix metalloproteinase activity of single 
live cancer cells in order to understand the biological and clinical relevance to 
cancer progression. 
 
4.1.1 Cancer metastasis and circulating tumor cells 
As reviewed in Chapter 2, cancer is one of the deadliest diseases imposing huge 
healthcare and economic burden on society. The predominant treatment 
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methods include surgical removal, chemotherapy and radiotherapy. Usually 
cancer patients go through a course of combinational treatments trying to kill 
malignant tumor cells. In most of the cases, although primary tumor is removed, 
cancer relapse could still take place at distant organs after years of treatment.  
The reason for cancer relapse is mainly due to cancer metastasis. Cancer 
metastasis is a highly complex, multi-stage process which involves the 
dissemination of tumor cells from a primary site to other parts of the body via 
circulating blood stream and the development of secondary tumors as shown in 
Figure 4.1. In fact, more than 90% of cancer related deaths are caused by 
metastasis [105]. 
Circulating tumor cells (CTCs) play a very important role in cancer metastasis 
as they circulate freely in peripheral blood serving as seeds for secondary tumor 
[106]. Some scientists believe once tumorigenic CTCs find a proper 
microenvironment, they will extravasate from blood vessel, enter healthy tissue 
and start to grow into a secondary tumor [107]. Some research has suggested 
tumor tissue could release CTCs into blood stream even at the early stages of 
disease [108]. Many studies have demonstrated the detection of CTCs helps to 
predict the cancer progression in patients and evaluate the treatment efficacy. 
For example, the enumeration of CTCs negatively correlates with the overall 
survival rate of late-stage cancer patients [106]. Furthermore, CTC count 
evaluated at different time points during systemic treatment is a reliable 
surrogate marker of treatment response [109]. CTCs are believed to carry 
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relevant information about the primary tumor that they come from. CTCs are 
believed to carry relevant information about the primary tumor that they come 
from. Preliminary studies have suggested that selecting therapies based on 
molecular characteristics of CTCs may improve treatment outcomes in patients 
[110]. Hence, CTCs hold significant clinical potential for cancer diagnosis, 
disease monitoring and therapeutic applications. 
 
4.1.2 Matrix metalloproteinase in tumor development 
MMPs comprise a family of 23 zinc-dependent endopeptidases that are part of 
the metzincin family of enzymes and are generally active on or near the cell 
surface. Most MMPs are secreted molecules, with small exception of some 
membrane-type MMPs with transmembrane domain. As central regulators of 
extracellular matrix (ECM), MMPs are critical in microenvironment 
remodeling by degrading ECM. The cleavage of ECM can serve many purposes, 
such as creating space for cell migration and modifying the activity of signaling 
molecules [111].  
In normal cases, the proteolytic activities of MMPs are carefully controlled and 
are only present when and where needed for tissue remodeling such as 
embryonic development, wound healing and modification of cell adhesion [112]. 
However, aberrant expression of MMPs has been implicated in pathological 
conditions for tumor development and cancer metastasis. In tumor development, 
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MMPs promote growth of cancer cells by cleaving insulin-growth-factor-
binding protein, thereby liberating growth factors [113]. MMPs also promote 
angiogenesis by increasing the bioavailability of the pro-angiogenic growth 
factors such as vascular endothelial growth factor and fibroblast growth factor-
2 [114]. In addition, MMPs promote migration and invasion of cancer cells by 
cleaving structural components of ECM, such as collagen type I and IV [113]. 
They help cancer cells intravasate and extravasate. Lastly, MMPs facilitate the 
epithelial-to-mesenchymal transition (EMT) — a transition that is associated 
with malignant behaviour — by cleaving the cell-adhesion molecule e-cadherin 
and by liberating transforming growth factor beta [115]. Therefore, it is 
important to study the MMP activity of heterogeneous tumor cells, including 
CTCs, in order to understand the aggressiveness and metastatic potential of the 





Figure 4.1 Illustration of cancer progression from survival from programmed 
death to metastasis at distant site. Along the progress, matrix metalloproteinases 
(MMPs) promote invasiveness of cancer cells and facilitate intra- and 
extravasation. (Adopted from Nature Review Cancer [116])  
 
4.1.3 Limitation of current technology in single-CTC functional study 
Despite the importance of CTCs in cancer progression, direct study on CTCs 
remained difficult because of their rarity. The number of CTCs is extremely low, 
comprising as few as one or two cells per 109 hematologic cells (mainly 
erythrocytes). Research has shown that CTCs are different from other 
hematologic cells in terms of surface molecule expression, size, stiffness and 
electrical property [52, 117-119]. Hundreds of microfluidic platforms have been 
developed to achieve accurate CTCs isolation from blood, leveraging their 
distinct tumor-specific surface markers and biophysical properties. Among 
those technologies, epithelial cell adhesion molecules (EpCAM)-based capture 
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and size-based sorting/filtration are the most popular approaches to enrich 
primary CTCs from blood sample [20].  
Though microfluidic platforms can isolate CTCs from hematological cells at 
fast rate and with good accuracy, single-CTC functional assay still remains 
challenging. The assay efficiency is mainly restricted by low CTC count. In the 
previous chapter, we developed an integrated droplet device to encapsulate rare 
cells with high single-cell encapsulation efficiency. When we tried to apply this 
device on primary CTCs assay, we realized the developed device had some 
drawbacks to process the rare clinical sample. 
First, the droplet size generated from the developed jetting device varies with 
cell size. Under jetting, the encapsulated cells are tightly packed in water and 
the size of cell-containing droplets depends heavily on cell size. As the droplet 
size varies, the amount of reagent loaded in every cell-containing droplet also 
differs, affecting downstream single-cell assay. This issue was subtle in the 
previous study because standard culture cell line has a more homogeneous size 
distribution. However, it became more serious for clinical samples, whose cell 
size is usually very heterogeneous compared with standard cultured cell lines. 
Secondly, droplets suffered from evaporation due to large surface-to-volume 
ratio. Cell-containing droplets produced under jetting was just 5 μm larger than 
the cells inside, so the total aqueous volume was small. As a result, cell-
containing droplets evaporated fast and eventually collapsed during long-time 
observation (e.g. 1 to 2 hours). Based on these technical difficulties, we need to 
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find out a method to resolve the problems associated with low CTC count, 
droplet uniformity and droplet long-term stability.  
 
4.1.4 Proposed technique and hypothesis 
Here, a microfluidic droplet technology is purposed to study matrix 
metalloproteinase activity of individual cultured cancer cells, including cultured 
CTCs. In order to ensure the accuracy of functional assay, carefully-washed 
cancer cells are encapsulated with FRET-based MMP substrate into uniform 
droplets under drippling regime. Droplet size is large enough to sustain high cell 
viability and counter the evaporation issue for a long period. As cancer cells 
secrete active MMPs into the droplet environment, the fluorogenic substrate 
will be cleaved and produce increasing fluorescent signals, corresponding to the 
proteolytic activity of individual cancer cells. Tapered microwell device was 
applied to realize in-vitro expansion of circulating tumor cell for droplet-based 
assay [120]. In this way, the concentration of CTCs can be boosted to around 
100 thousand per milliliter after 3-week culturing. The expanded CTC 
population could relieve the poor single-cell encapsulation problem. We 
hypothesized that we could observe brighter fluorescent signals for invasive and 
metastatic cancer cell lines due to their higher level of MMP activity. We then 
apply the developed system to study the MMP activity level of patient-derived 
circulating tumor cell samples to evaluate the potential of CTCs to extravasate 
from blood vessel and provide insights on disease status. The experimental 
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Figure 4.2 Schematics of droplet-based cultured-CTC MMP assay. Cultured 
CTCs are harvested from microwells and stained with CD-45 to distinguish 
WBC residues before they are encapsulated with MMP reagent into droplets. 
Fluorescence intensity of cell-containing droplets are measured after a certain 
period of incubation in an observation chamber.  
 
4.2  Material and methods 
4.2.1 Device design and fabrication 
The main microfluidic device was a cross-flow droplet generator. It had three 
inlets for oil, cell solution and reagent, and one droplet outlet. The channel width 
and height were both 50 µm. Unlike the previous jetting project, droplets were 
produced under drippling mechanism. Therefore, the droplet size was similar to 
the channel dimension, about 50 to 60 µm. Droplet observation chamber was 
designed as a rectangular shape with 15mm length and 3 mm width and 
fabricated with a height of 50 µm. The total volume of the chamber was about 
2.3 µL that may contain more than 2000 droplets as the volume of individual 
droplets was about 0.1 nL. Circular posts with 200 µm diameter were added 
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inside the observation chamber to prevent chamber collapse due to the low 
aspect ratio of chamber height to width. The device fabrication process was the 
same as described in Chapter 3, namely soft-lithography of 
polydimethylsiloxane (PDMS) using a SU-8 mold followed by an irreversible 
plasma bonding. 
The tapered microwell design was used for circulating tumor cell (CTC) in-vitro 
culture. Each microwell had an elliptical opening of 250 × 150 µm. The slope 
profile was tapered to the microwell bottom. The microwell depth was about 
150 µm. The 1st generation of the tapered microwell was fabricated on uncoated 
60mm petri dishes (Becton Dickinson Corp, USA) using laser engraving/cutting 
system (VLS-2.3, Universal Laser System Inc, USA) [120]. The 2nd generation 
of microwell with better device uniformity and surface finishing was produced 
on PDMS with sophisticated soft-lithography technique [121]. The SU-8 mold 
was directly fabricated onto a chrome mask (Infinite Graphics, Singapore) with 
elliptical patterns. Firstly, a thick layer of SU-8 was coated on the chrome 
surface of the mask. Next, an opal diffusor glass (Edmund Optics Inc, USA) 
was attached to the other surface of the mask. UV shined through the opal 
diffusor glass and exposed onto the thick SU-8 layer. The diffused UV light 
created a hill-shape pattern with a slope on the SU-8 layer. After SU-8 
development and hard-baking, the hill-shaped SU-8 mold can be used to 
produce PDMS microwell via soft-lithography. CTCs were directly cultured on 




4.2.2 Cancer cell line culture and preparation 
Three commercially available human breast cell lines, MCF-7 (breast cancer 
cell), MCF-10A (normal breast epithelial cell) and MDA-MB-231 (breast 
cancer cell), were used to characterize device performance and protease activity 
of cultured cancer cells in this work. The MCF-7 cells (ATCC® HTB-22TM, 
USA) and MDA-MB-231 cells (ATCC® HTB-22TM, USA) were cultured in 
high-glucose Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen, USA) 
supplemented with 10% fetal bovine serum (FBS) (Invitrogen, USA) and 1% 
penicillin-streptomycin (Invitrogen, USA). The MCF-10A cells (ATCC® CRL-
10317TM, USA) were cultured in MEBM supplement with MEGMTM 
SingleQuot and cholera toxin (Lonza, Switzerland). The cells were cultured 
separately in T-25 flasks (ThermoFisher, USA) at 37 ºC in a humidified 
atmosphere with 5% (v/v) CO2 till 80% confluence. The cells were sub-
cultivated two to three times a week with medium replaced every 48 hours. 0.01% 
trypsin and 5.3mM EDTA solution (Lonza, Switzerland) was used to harvest 
cells from culture flask. The trypsinization duration for MCF-7 and MDA-MB-
231 was 5 minutes, but the duration for MCF-10A was 10 to 15 minutes because 
MCF-10A tended to attach flask surface more firmly.  
For single-cell encapsulation experiment, the cultured cancer cells were diluted 
in 1x phosphate buffer saline (PBS) with 10% OptiPrep density gradient 
medium (Sigma, USA) to prevent cell precipitation during operation [66]. The 
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harvested cells were washed with PBS buffer thoroughly for 3 times to clean 
out contaminants in the cell solution or attached onto the cell membrane. For 
single-cell MMP assay experiment, cancer cells were synchronized using 
serum-free medium for at least 6 hours to minimize the fluctuation of MMP 
signal due to different cell cycles. Cell solution was always filtered using 40 µm 
stringer (Becton Dickinson, USA) to remove large cell clusters. The final cell 
concentration was adjusted to 1 million per ml with proper dilution. For cell 
viability evaluation, certain concentration of live/dead viability kit 
(ThermoFisher, USA) was added to cell solution according to the product 
instruction.   
 
4.2.3 Circulating Tumor cell culture 
Blood samples were obtained from different cancer patients. All patients gave 
their informed consent for inclusion in this study. The study of cultured CTCs 
was approved by our institutional review board and local ethics committee 
(DSRB reference 2012/00105, 2012/00979, 2010/00270 and 2010/00691). All 
blood specimens were collected in sterile EDTA-coated vacutainer tubes 
(Becton Dickinson, USA) and processed within 10 hours after blood withdrawal 
to reduce blood clotting and maintain cell viability. Whole blood was lysed with 
red blood cell (RBC) lysis buffer (Life Technologies, USA) for 5 minutes with 
gentle mixing, centrifuged to remove plasma and lyse RBC fragments, and then 
washed once with sterile PBS. All nucleated cells (CTC and white blood cells) 
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were re-suspended in fresh high-glucose DMEM with 10% FBS and 1% 
penicillin-streptomycin and seeded into the microwell device. The microwell 
device was rinsed and incubated with 70% ethanol for at least 15 minutes for 
sterilization before cell sample seeding. 
Cells were kept at 37 ºC in 5% CO2 and 1% O2 under humidified condition. The 
hypoxia condition was to mimic the realistic microenvironment of tumor niche 
[122].The culture medium was replaced every 2 to 3 days with minimum 
disturbance to the microwells to avoid cell loss. Cultured CTCs tended to form 
cluster during the culture process. Clusters were harvested and dissociated with 
pipetting for 3 minutes with 0.01% trypsin and 5.3mM EDTA.  
As reported before, small population of residual leukocytes were found from 
the cultured CTC population [120]. Hence, cells harvested from microwell 
culture were stained with phycoerythrin (PE) conjugated CD45 antibody maker 
(1:10 ratio, Miltenyi Biotec Asia Pacific, Singapore) for 15 minutes on ice to 
differentiate leukocytes from cultured CTCs.  
 
4.2.4 Device operation 
In experiment, cell solution, reagent and oil (HFE-7500, 3M, USA) were 
pumped into the microfluidic droplet generator at different flow rates using 
syringe pumps (Harvard Apparatus, USA). The microfluidic device was 
mounted on an inverted phase contrast microscope (Olympus IX71, Japan) 
equipped with a high speed camera (Phantom, USA). The droplet generation 
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process was monitored and recorded using the high speed camera. The captured 
videos were later analyzed using ImageJ software (https://imagej.nih.gov/ij/, 
National Institute of Health, USA). Collected droplets could be incubated in 
fabricated observation chamber at room temperature. Fluorescent images of 
cell-containing droplets were captured by another epi-fluorescent microscope 
equipped with a 12-bit EMCCD camera (iXonEM + 885, Andor Technology, 
USA). Matrix metalloproteinase activity were assayed using FRET-based 
substrate Pepdab010 (Biozyme Inc, USA), which is sensitive to MMP-9 and 
ADAM-17 [62]. The substrate was designed with a fluorescent quencher and a 
fluorophore at two different ends of a specially-sequenced peptide. The 
fluorescent images were acquired using Metamorph® software (Molecular 
Devices, USA) and analyzed using ImageJ (https://imagej.nih.gov/ij/, National 
Institute of Health, USA). The MMP signals of single cells were calculated by 
subtracting the average background intensity of empty droplets from the 
individual intensity of cell-containing droplets. 
 
4.3  Results and discussion  
4.3.1 Change in oil operation 
In this project, droplet jetting was not required as the single-cell encapsulation 
efficiency for rare clinical sample was improved by in-vitro culture rather than 
size-based differentiation. Therefore, previously-used mineral oil was replaced 
by fluorocarbon oil HFE-7500, which was a more commonly-used oil in single-
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cell study. Adopting new oil phase brought some changes on the droplet system 
due to distinct physical properties.  
Firstly, the dynamic viscosity of HFE-7500 fluorocarbon oil is 7.7 × 10-4 Pa s 
[123], which is even lower than the dynamic viscosity of water. Such a low 
viscosity made the operation of microfluidic device relatively easy. Oil fluid 
could respond to flow rate adjustment almost spontaneously so that steady flow 
condition could be achieved quickly. However, low viscosity made droplet 
generation more difficult than before, as the friction force between water and 
fluorocarbon oil became weak. The weak interfacial friction force led to a 
reduced shearing effect on the water phase, which became less likely to be 
broken into mono-dispersed droplets. Therefore, the flow rate of fluorocarbon 
oil was always kept at least two times higher than the flow rate of water phase 
in order to have enough pinching effect at the cross-flow junction. Meanwhile, 
the surface wetting of the device was also important. The PDMS surface must 
recover its hydrophobicity after plasma bonding to effectively prevent water 
solution from sticking onto the device surface.  
Secondly, the fluorocarbon oil has a low boiling temperature and a fast 
evaporation rate, compared with mineral oil. Oil phase evaporation could cause 
problems in long-term droplet signal detection because of droplet location shift, 
shape change, and coalescence. In order to slow the evaporation process down, 
once filled with droplets, the observation chamber was closed with double 
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clamps at inlet and outlet tubing. The connection ports were also sealed with 
liquid PDMS.  
 
4.3.2 Fluorophore leaking prevention 
Apart from change in oil operation, new problem of fluorescence leaking 
occurred in the static droplet detection process after using fluorocarbon oil. In 
preliminary test using diluted trypsin and MMP substrate, fluorescent signals 
leaked from water droplets into ambient oil after 40-minute stationary 
incubation in the observation chamber as shown in the figure 4.3(A). The 
fluorogenic MMP substrate we used in the new droplet system were the same 
as what we used for the previous project. Besides, the same fluorocarbon oil 
was successfully used for droplet-based fluorescent detection [124]. So the 
investigation was focused on the change of droplet configuration.  
Soon, we found that the root cause of fluorescence leaking was the interaction 
between plasma treated PMDS layer and droplets. Unlike in the previous jetting 
project where droplets were small, the droplet size was about 60 μm. As the 
observation chamber height was 50 μm, all droplets were actually squeezed by 
the chamber ceiling and floor. As a result, each droplet had a large contact area 
with PDMS chamber surfaces. If the hydrophobicity of PDMS surface was not 
fully recovered from plasma treatment, fluorescent molecules could stick to the 
activated PMDS surface and then enter the surrounding oil phase.  
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Results from water contact angle tests later confirmed that overnight baking at 
70 ºC, a protocol established from the previous project, could not fully recover 
the hydrophobicity of plasma-treated PDMS surface as a water drop spread out 
on the PDMS surface with a small contact angle. In order to accelerate the 
recovery process, the PDMS baking temperature was increased to 170 ºC since 
higher temperature facilitated the diffusion of low molecular weight silicone 
fluid from the PDMS bulk to the PDMS surface to regain surface 
hydrophobicity [125]. The baking temperature should never exceed 250 ºC 
because such high temperature could break the polymer bond of PDMS and 
cause cracks.  
A verification test was conducted using the observation chamber prepared under 
overnight PDMS baking at 170 ºC. Two types of droplets were generated and 
mixed together in the observation chamber. The first type of droplets contained 
0.1x trypsin and MMP substrate as positive control and the second type of 
droplets contained PBS and MMP substrate as negative control. Positive control 
droplets had high fluorescence intensity as trypsin molecules cleaved the 
substrate at very high rate. In contrast, negative control droplets had minimum 
fluorescence intensity. By monitoring the change of fluorescence intensity of 
positive and negative control droplets and oil background over time, we could 
clearly observe whether fluorophore leaking occurred among positive droplets, 
negative droplets and oil solution.  
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Over 70 minutes, we did not observe any signs of fluorophore leaking as shown 
in Figure 4.3(B). The quantified fluorescence intensity plotted in Figure 4.3(C) 
demonstrated the intensity of positive droplets decreased a bit over time while 
that of negative droplets and oil background did not increase. The reduction of 
fluorescence intensity of positive droplets might be caused by photo-bleaching, 
which was frequently observed other experiments before [126]. Based on this 
result, it was proved that baking the PDMS observation chamber at 170 ºC for 
overnight could effectively prevent fluorophore leaking for long-term stationary 
fluorescence detection.  
 
Figure 4.3 (A) Two fluorescent images showing fluorescent leaking where oil 
medium demonstrated fluorescence. (B) left brightfield image of both positive 
(trypsin + substrate) and negative (PBS + substrate) control droplets mixed 
together in an observation chamber that was baked at 170 ºC overnight; right 
corresponding fluorescent image after 1-hour incubation showing only positive 
droplets had fluorescent signals. (C) Quantified fluorescence intensity of mixed 
positive and negative droplets over 70 minutes, proving no fluorescent leaking 




4.3.3 Single-cell encapsulation characterization 
The single-cell encapsulation efficiency of the droplet generator was 
characterized using MDA-MB-231 cells. As no intervention was conducted to 
enhance the encapsulation efficiency, the single-cell encapsulation rate could 
be predicted using Poisson distribution as explained in Chapter 3. The size of 
droplets was 61 ± 3.5 µm, corresponding to about 0.1 nL of volume. When the 
input cell concentration was 1 million per mL (λ = 0.1), the measured single cell 
encapsulation efficiency was about 7.8 ± 1.3%; when the input cell 
concentration was 4 million per mL (λ = 0.4), the measured single cell 
encapsulation efficiency increased to 19.8 ± 3.4%. The quantified single-cell 
rate based on experiment demonstrated a good agreement with Poisson model 
as shown in Figure 4.4. When cultured CTC sample was processed, the single-
cell encapsulation efficiency ranged from 1 to 5% since the sample 
concentration varied from 100k to 500k cells per mL. 
 
Figure 4.4 (A) Droplet encapsulation image of MDA-MB-231 cells with the 
concentration of 4 million per mL, where the majority of droplets are empty. 
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(Scale bar = 50 µm) (B) Measured single-cell encapsulation efficiency under 
three different cell concentrations. As no intervention is added to improve the 
encapsulation efficiency, the results simply follow Poisson distribution. 
(Sample size = 1102 droplets)  
 
4.3.4 Viability characterization of cell in droplet 
Viability test was conducted on freshly harvested MCF-7, MCF-10A and MDA-
MB-231 cells to investigate the survival rate over 2 hours. The size of droplet 
generated under drippling was about 60 μm in diameter, which was much larger 
than the cell size. This large droplet volume provided a favorable environment 
to extend single-cell survival because the droplets carried a large number of 
nutrients. In addition, the accumulation of metabolites inside large droplets was 
slowed to have few adverse effects on cells. Moreover, as the oxygen solubility 
in fluorocarbon oil is much higher than mineral oil, the problem of lack of 
oxygen during cell incubation would not appear [127]. The single-cell viability 
across three cell lines are presented in figure 4.5. We could see the 1-hour 
survival rate was above 90% for all three cell lines. The survival rate reduced 
by 5 to 10% for one more hour of incubation. MCF-10A cells had the largest 
survival rate drop over the 2-hour monitoring. It could be because MCF-10A 
cells were less resilient than the two breast carcinoma cell lines and they needed 




Figure 4.5 Survival rate of three breast epithelial cell lines in 50 µm droplets 
after 1-hour and 2-hour incubation. Approximately, over 90% cells remain 
viable for 1-hour incubation and the survival rate decreases by 5% for another 
1-hour incubation. Total sample size = 346 cells. 
 
4.3.5  Time-lapse MMP functional assay on single cells 
MDA-MB-231 cells were used to investigate the dynamics of single-cell MMP 
activity over 1 hour. The harvested MDA-MB-231 cells were carefully washed 
with PBS to remove potential contaminants on the cell surface. Washed cells 
were encapsulated into droplets with 20 μM MMP substrate. As the protease 
produced by cancer cells cleaved the peptide bridge of fluorogenic substrate, 
the fluorophores were released from quenchers leading to an increase of 
fluorescence intensity.  
The time-lapse single-cell assay results are presented in the Figure 4.6. The 
fluorescent signals of cell-containing droplets had an average increase of 270 
a.u. for 70 min incubation with large standard deviation due to cell 
heterogeneity. In contrast, the signals of empty droplets had an average increase 
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of 50 a.u. with much smaller standard deviation. The increasing fluorescent 
signal of empty droplets were caused by hydrolysis of peptide bridge, which 
was much slower than the proteolytic cleavage by specific MMP.  
During the time-lapse detection, it was found that the cells signal generated from 
cultured cancer cells did not reach the obvious plateau status, which was 
observed in the previous jetting project described in Chapter 3. This might be 
because the cell-friendly environment in the current droplet system did not 
impede the protease production of cancer cells within the observation period. 
Moreover, we did not observe any sudden onset of fluorescence intensity 
increase for cell-containing droplets, except for a small group of unhealthy cells 
that were undergoing apoptosis during observation. Once a cell underwent 
apoptosis, the membrane integrity would be compromised resulting in leaking 
intracellular proteases into ambient environment and abrupt increase of 
fluorescent signals. 
Because of no saturation and sudden change of fluorescent signal, we found the 
fluorescent intensities of individual cells after 1-hour incubation correlated well 
with the increasing slope of individual signal profiles. Based on this observation, 
we decided to replace time-lapse detection with end-point detection for 
subsequent cell assays. This is because we can observe a large group of droplets 
at the same time without considering droplet movement in the observation 
chamber when doing 1-hour end-point detection. On the contrary, the time-lapse 
fluorescent detection was more difficult because droplets could move around 
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during the 1-hour observation which increased the difficulty in tracking the 
fluorescent change of individual droplets at every time point. In order to obtain 
distinguishable fluorescent signals from cell containing droplets, the incubation 
time was set 1 hour. At 1-hour time point, the signals from single cancer cells 
were high enough to be discriminated from the background signals of empty 
droplets while the majority of the cells still remained viable and healthy. In the 
subsequent experiment, the 1-hour fluorescent signals from cell-containing 
droplets were obtained by subtracting the individual intensity of cell-containing 
droplets by the average intensity of empty droplets. 
 
Figure 4.6 Time-lapse fluorescent signals from cell-containing droplets and 
empty droplets over 70 minutes. Cell-containing droplets have a large increase 
in the fluorescence intensity with a big standard deviation compared with empty 
droplets. Insets: fluorescent images of cell-containing and empty droplets at 




4.3.6 End-point assay on various cell lines 
All three cultured cell lines, MCF-7, MCF-10A and MDA-MB-231, were 
characterized using the single-cell protease assay platform. The end-point 
detection was carried out after 1-hour droplet incubation at room temperature. 
Based on the results shown in Figure 4.7, we can easily observe the inherent 
cell heterogeneity among the same types of cultured cell line. Even though those 
cells within one cell line were cultured under the same condition and 
synchronized before single-cell assay, their phenotypes in terms of protease 
activity still differed from each other.  
As shown in Figure 4.7 (A), MDA-MB-231 cells had a signal intensity of 
129.66 ± 52.40 a.u.; MCF-7 cells had a signal intensity of 65.02 ± 37.53 a.u. 
and MCF-10A cells had a signal intensity of 48.34 ± 23.51 a.u. Among all three 
cell lines, MDA-MB-231 had the greatest standard deviation of the fluorescent 
signals, suggesting that MDA-MB-231 breast cancer cells had the most diverse 
proteolytic activities at single-cell level. Some MDA-MB-231 cells had weak 
MMP secretion corresponding to the fluorescence intensity around 50 a.u., but 
some other cells had a much stronger MMP activity with the fluorescence 
intensity above 200 a.u. Provided MDA-MB-231 cell line was derived from an 
aggressive breast cancer tissue (triple-negative type) and had strong potential to 
metastasize [128], we speculated that aggressive cancer types are generally 
poorly-differentiated and have a highly heterogeneous cell behavior in terms of 
proteolytic activity.  
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Apart from the heterogeneity within a cell line, we also compared the overall 
fluorescent signals obtained from all three cell lines. Interestingly, the average 
fluorescence intensity had a decreasing trend, from MDA-MB-231 to MCF-7 
and MCF-10A. T-tests results revealed that the intensity level of the metastatic 
MDA-MB-231 cells was significantly higher than that of the less invasive 
MCF-7 cells, which was also significantly higher than that of the breast 
epithelial MCF-10A cells as shown in Figure 4.7. As MMPs are essential 
enzymes to degrade basal membrane and promote angiogenesis, they have been 
demonstrated with elevated expression among invasive cancer cells and have 
been chosen as one of the biomarkers to indicate cancer invasiveness. High 
expression level of MMP also correlates low epithelial cell adhesion molecule 
(EpCAM) expression on the cell membrane since MMP could cleave EpCAM 
at the extracellular site transforming the cancer cells toward mesenchymal type. 
Previous studies have proven MDA-MB-231 cells generally have low EpCAM 
expression and undergo epithelial-mesenchymal transition (EMT) to become 




Figure 4.7 (A) Single-cell MMP assay results on MDA-MB-231, MCF-7 and 
MCF-10A cell lines obtained after 1-hour incubation. Three cultured cell lines 
are significant different from each other (asterisk refers to p-value <0.01) Total 
sample size = 178 cells. (B) Fluorescent images of different cultured cells in the 
droplets (red circle: MDA-MB-231; green circle: MCF-7 and blue circle: MCF-
10A). 
 
4.3.7 Single cultured CTC MMP functional assay 
Next, we performed single-cell MMP functional assay on cultured CTC samples 
obtained from breast cancer patients. They were carefully characterized using 
nuclear-cytoplasmic ratio and immunostaining of cytokeratin (CK) and CD-45 
as described in the previous work [120]. Clusters containing an increasing 
number of cytokeratin-positive (CK+) cells appeared after 2 weeks, while most 
blood cells disappeared with time. After culturing 2 to 3 weeks, CTC sample 
were harvested from the microwell culture device. Clusters of cultured CTCs 
were broken by repeated pipetting. As the harvested cancer cells were always 
present with some WBC residues, such as macrophages and monocytes, 
phycoerythrin (PE) conjugated CD45 antibody was used to distinguish the 
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residual WBCs from CTCs [130]. Only droplet signals from CD45-negative 
cells were considered as MMP activity of cultured CTCs.  
Before performing end-point assay, we first conducted the time-lapse study on 
cultured CTCs to acquire the single-cell profile of MMP activities over 50 
minutes. The measured results assured that no fluorescence saturation and 
sudden signal change happened during the detection period, similar to the 
results of cell lines, as shown in Figure 4.8(A). Therefore, the slope of individual 
MMP activity could be represented by the final intensity at 1-hour time point.  
Then, the 1-hour end-time-point assay was performed on more than 300 
cultured CTCs obtained from a breast cancer patient, who was at 2nd time point 
in the treatment course. We found the overall MMP activity level of single 
cultured CTCs demonstrated a spindle pattern with an average intensity of 59.2 
a.u. and a standard deviation of 16.3 a.u. as shown in figure 4.8(B). About 3% 
of cultured CTCs had a fluorescence intensity over 100 a.u., which correlated 
with intensive MMP activity inside the droplets. Meanwhile, the co-existing 
WBCs in cultured CTC sample demonstrated an average fluorescence intensity 
of 47.2 a.u. and a standard deviation of 15.4 a.u. No cultured WBCs had a 
fluorescence intensity over 100 a.u. Most of MMP activities of WBC residues 
were below 80 a.u. The average fluorescence intensity of empty droplets as 
background signal was about 21.7 a.u.  
Another batch of cultured CTCs was applied to the single-cell MMP assay. The 
CTCs were obtained from another breast cancer patient, who was also at 2nd 
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time point in the treatment course. The overall MMP activity level of single 
cultured CTCs also demonstrated a spindle pattern with an average intensity of 
47.5 a.u. and a standard deviation of 20.4 a.u. as shown in figure 4.8(C). 
However, more cultured CTCs from this patient demonstrated low MMP 
activity level as 78% of the cultured CTCs had a fluorescence intensity below 
60 a.u. This result may indicate this cancer patient responded quite well to the 
cancer treatment as the overall MMP secretion from CTCs was kept at low level. 
Very few cultured CTCs demonstrated high MMP activity with the fluorescence 
intensity over 100 a.u., which may be due to their resistance to the treatment. 
Meanwhile, the co-existing WBCs in this cultured CTC sample had an average 
fluorescence intensity of 34.9 a.u. and a standard deviation of 18.3 a.u. The 
average fluorescence intensity of empty droplets as background signal was 
about 18.4 a.u., which was comparable to the previous assay.   
In addition, we studied the MMP activity level on a batch of cultured CTCs 
retrieved from a lung cancer patient. The pathological mechanisms of lung 
cancer and breast cancer are different, so are their MMP activity levels. The 
cultured lung CTCs displaced a low MMP activity level with an average 
intensity of 33.3 a.u. and a standard deviation of 9.6 a.u. as shown in Figure 4.8 
(D). No cultured CTC had a fluorescence intensity above 100 a.u. Moreover, 
many leukocytes were found in the cultured sample, which had a very diverse 





Figure 4.8 (A) Time-lapse MMP activity signals from 12 cultured breast CTCs 
over 50 minutes. (B) and (C) two profiles of end-point MMP activity signals 
from two cultured breast CTC samples after 1-hour incubation. Although both 
samples were retrieved from breast cancer patients at the same treatment stage, 
their MMP activity profiles were different due to distinct responses to treatment. 
(D) End-point MMP activity signals from a cultured lung CTC sample, 
demonstrating a low activity level from CTCs and the presence of a large 
number of leukocytes. (Total number of cultured CTCs = 634, total number of 
WBCs = 343)  
 
4.4  Conclusions 
In this chapter, we demonstrated the use of MMP functional assay on both 
cultured cell lines and cultured CTC samples using a droplet microfluidic device. 
The approach was capable of quantifying MMP activities of single viable cancer 
cells suspended in water-in-oil droplets rapidly and efficiently. The high 
sensitivity of the technique enabled the detection of distinct MMP activities 
among various cell sample. It was observed that highly metastatic cancer cells 
89 
 
(MDA-MB-231) have more intensive MMP activities than less invasive cells 
(MCF-7 and MCF-10A), suggesting MMP activity could be utilized to evaluate 
single-cell invasiveness. The single-cell MMP assay on cultured CTCs, 
obtained from cancer patients undergoing treatments, demonstrated diverse 
MMP profiles even though patients were at the same stage of treatments. The 
obtained single-cell MMP activity profile could shed insights on the functional 
heterogeneity among clinical CTC samples, and eventually provide treatment 





Chapter 5. Single leukocyte protease study using integrated 
droplet platform 
5.1  Introduction 
In the single-cell functional assay of cultured circulating tumor cells (CTCs) 
described in Chapter 4, white blood cells (WBCs) were always found present in 
the cultured CTC samples as contaminants [120]. The proteolytic activity of 
WBCs was rather similar to cultured CTCs after two-week hypoxia culturing. 
Literatures have suggested that proteolytic activity, especially matrix 
metalloproteinase (MMP) activity, of WBCs are related to cell migration, 
inflammation response, immune defense and other diseases [131-133]. 
However, ensemble measurement of WBCs may be inaccurate because of the 
high cellular heterogeneity. Indeed, leukocyte heterogeneity has been reported 
critical to therapeutic outcomes [134]. Therefore, it would be of our interests to 
study the functional heterogeneity of WBCs at single cell level. In the following 
chapter, we will explore how to accurately study protease activity of single 
leukocytes using an integrated droplet microfluidic device. 
 
5.1.1 Background of single leukocyte study 
Leukocyte, also known as white blood cell, is an important component of 
hematological cells responsible to immune defense against foreign invaders. As 
reviewed in Chapter 2, leukocyte plays an important role in many acute and 
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chronic diseases, such as sepsis, asthma and cancer [135, 136]. Direct functional 
assay of leukocytes could offer rapid evaluation of patient’s immune function 
and disease statues. However, it is rather difficult to achieve due to the highly 
heterogeneous nature of leukocytes. 
The current analytical methods for leukocyte study includes peripheral blood 
smear and flow cytometry. They mainly measure morphological property and 
surface biomarker expression of individual leukocytes [137, 138]. These 
methods are insufficient to measure protein secretion of individual cells as well 
as investigate the functional heterogeneity of patients’ immune capability.  
Recently, microfluidic technologies have been widely applied to study single 
cells, including leukocytes. For example, individual leukocyte differentiation 
has been analyzed using single-cell impedance microfluidic cytometry [139, 
140]. In addition, the measurement of cytokine production of single T 
lymphocytes was also achieved in gel particle with the help of ELISA-based 
bead assay [141]. However, measurement of comprehensive biochemical 
signals such as protease secretion still remains challenging.  
 
5.1.2 Difficulty on single leukocyte functional study 
Droplet microfluidics have recently emerged as a versatile tool for single-cell 
analysis as discussed in Chapter 2, 3 and 4. Although contamination across 
droplets could be greatly controlled by isolating cells within droplets, pre-
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encapsulation contamination could still occur for highly secretion-active cells, 
such as leukocytes [142]. When leukocytes are stored in a syringe before 
encapsulation, a lot of soluble contaminant biomolecules are secreted into the 
solution and then compartmentalized into individual droplets randomly. These 
contaminant biomolecules unavoidably deteriorate the accuracy of downstream 
analysis as shown in Figure 5.1. Even worse, majority of leukocytes have a 
limited life time (e.g. two to three days). As a result, some leukocytes may die 
in the syringe and release significant number of intracellular biomolecules into 
the surrounding solution, limiting long-term robustness of droplet based single 
leukocyte analysis.  
Dilution of cell solution might be helpful to reduce the contaminant 
concentration but this would inevitably reduce the cell concentration and 
decrease the single-cell encapsulation efficiency. Therefore, washing step 
before encapsulation becomes essential for single leukocyte study. 
 
Figure 5.1 (A) and (B) Illustrations of a commonly-used cell injection method 
for cell encapsulation. Millions of cells continually release biomolecules into 
the mixed solution while storing in the syringe. These free biomolecules, as 
contaminants, are encapsulated into droplets randomly, affecting downstream 
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analysis. (C) Fluorescent image of droplets produced from leukocyte solution 
using the method described in (A) and (B). Due to the pre-encapsulation 
contamination, most of empty droplets became bright and undistinguishable 
from cell-containing droplets (green: matrix metalloproteinase signal; red: CD-
45 stained WBC) (scale bar = 50 µm). 
 
5.1.3 State-of-the-art for microfluidic cell washing 
Conventional washing method requiring centrifugation and cell re-suspension 
is difficult to be achieved in microfluidics. Moreover, live leukocytes would still 
continually release various proteins and cause contamination even after washing. 
Hence, an in-situ microfluidic washing method is necessary for accurate and 
robust single leukocyte functional assay. 
Inertial microfluidics has been widely deployed to purify cell samples from 
small debris [143-145]. More recently, Dudani demonstrated a rapid inertial 
solution exchange method to enrich microvesicles from acellular contaminants 
using antibody-coated polystyrene beads [146]. Essentially, the method was to 
separate large antibody-coated beads (20 μm) with captured exosomes and small 
acellular contaminants (<5 μm) by focusing them at different laminar positions. 
However, the inertial microfluidic methods are unable to resolve biomolecular 
contamination because the contaminant size is at nanometer scale. 
Magnetic particle-based droplet washing has also been demonstrated to extract 
assay target from a contaminated droplet to a clean droplet for better detection 
resolution and immuno-staining [147]. Nevertheless, the dependence of 
antibody binding limits the downstream application as the binding could alter 
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the cell property and is irreversible. Furthermore, the usage of antibody largely 
increases the cost for each assay.  
Chen and his colleagues proposed to use laminar flow and side-based sorting to 
achieve single leukocyte on-chip immune-staining [148]. Based on their 
measurement, the excessive antibody added in the system could be effectively 
washed away without contributing to the background fluorescence intensity. 
Similar design could be leveraged to achieve noise-free single leukocytes 
proteolytic assay. 
 
5.1.4 Proposed technique and hypothesis 
Here, an integrated droplet microfluidic device is proposed to study protease 
activity of individual leukocytes with solving the high pre-encapsulation 
contamination issue encountered in direct assay of fresh leukocytes. The 
microfluidic device consists of an upstream cell guiding array to purify 
leukocytes from a contaminated solution and a downstream droplet generator to 
compartmentalize individual purified cells into droplets for subsequent analysis. 
We hypothesize that we could suppress the pre-encapsulation contamination, 
reduce the false readouts and hereby improve the accuracy of cell-containing 
droplets using the developed device. We could apply the device to study 
functional heterogeneity among fresh leukocytes at naïve status and probe 




5.2  Materials and methods 
5.2.1 Device design 
The microfluidic device consisted of an upstream cell guiding array and a 
downstream cross-flow droplet generator as shown in Figure 5.2. Buffer and 
cell solution inlets were located at the same side of cell guiding array. The ratio 
of inlet width for buffer and cell solution was maintained at 1:1. The cell guiding 
array was 2.6 cm long and 800 μm wide with circular micropillars inside. The 
circular micropillars array was designed based on deterministic lateral 
displacement (DLD) design as discussed in Chapter 3. The pillar diameter and 
pillar gap was set 30 μm, which was sufficiently large for leukocytes to pass 
through. The row shift distance was set 1.5 μm. The resulting separation 
threshold was 10 μm approximately. Since the size of leukocyte is about 12 μm, 
the cells could be effectively deflected from original solution and enter clean 
buffer solution. At the end of DLD guiding array, the bifurcation point was set 
at 180 μm away from channel wall near the buffer solution side to prevent 
contaminant diffusing into droplet branch. The entrance width of waste channel 
is 620 μm. In this way, after passing through the cell guiding array, most of fluid 
would enter the waste outlet and only a small fraction of it would enter the 




Figure 5.2 Device schematics showing an integration of a cell washing array 
and a droplet generator. Insets ① to ④ illustrate the flow conditions at the 
individual device positions. At ①, cells solution flows with buffer solution in 
parallel. At ② and ③, cells are gradually diverted away from the original cell 
solution while contaminants are still confined in the original solution due to 
laminar flow. At ④, washed cells are immediately encapsulated at the droplet 
generator with minimum level of contamination. 
 
5.2.2 Device fabrication 
The devices were fabricated in polydimethylsiloxane (PDMS) (Dow Corning, 
USA) using standard soft-lithographic microfabrication techniques described in 
previous chapters. In this work, cleaned PDMS device was irreversibly bonded 
to a PDMS sheet which was prepared by casting PDMS into a Petri dish. After 
plasma bonding, the device was baked at 170 ºC, instead of 70 ºC, on a hotplate 
for overnight. The reason to incubate the device at such a high temperature is to 
recover the hydrophobicity of fabricated device, especially near the droplet 
generator [125]. Otherwise, buffer solution flushed from the cell guiding array 
would stick to the channel wall at the droplet generation junction and could not 
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be compartmentalized by oil solution to form monodispersed droplets. 
 
5.2.3 WBC retrieval from whole blood 
Fresh leukocytes were retrieved from whole blood of healthy donors via red 
blood cell (RBC) lysis [149]. Whole blood was firstly added to pre-warmed 
RBC lysis buffer (eBioscience, USA) with a volume ratio of 1:9 and then 
incubated in water bath at 37 ºC for 5 minutes. The lysed blood was centrifuged 
at 1200 rpm for 5 minutes. The resulting cell pellet, consisting of leukocytes 
and some RBC debris, was washed once with PBS carefully. The washed cells 
were then re-suspended in a buffer solution containing 1% bovine serum 
albumin (BSA) (ThermoFisher Scientific, USA), 0.1% Poloxamer 188 (Sigma 
Aldrich, USA) and 20% OptiPrep density gradient medium (Sigma Aldrich, 
USA). The addition of Poloxamer was to prevent leukocytes from sticking to 
microfluidic device or tubing during experiment [150] and the addition of 
density gradient was to avoid cell sedimentation due to gravitational force [73]. 
For cell washing experiment, leukocytes were stained with Hoechst nucleus 
stain (ThermoFisher Scientific, USA) for cell visualization under high speed 
camera. For leukocyte viability test and MMP secretion assay, propidium iodide 
(PI) dead stain (ThermoFisher Scientific, USA) was applied on fresh leukocytes 
to indicate viability of individual cells. Before cell encapsulation experiment, 
the stained leukocyte solution was always filtered with 20 µm stringer (Becton 
Dickinson, USA) to remove large cell aggregation and fibronectin clots formed 
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during storage. The concentration of stained leukocytes was diluted below 500 
k/mL before injecting cells into microfluidic device. Higher cell concentration 
was likely to cause device clogging. 
 
5.2.4 Device operation 
Before testing, the microfluidic device was primed with 70% ethanol for 1 
minute in order to make sure no air bubble was trapped in the channel. Next, 
the device was flashed with complete buffer solution (with BSA, Poloxamer and 
OptiPrep) for 5 minutes. After washing, the cell solution, PBS buffer and 
fluorocarbon oil (HFE-7500) (3M, USA) were pumped into the microfluidic 
device using syringe pump (Harvard Apparatus, USA). The PBS buffer was 
changed into MMP substrate solution in single leukocyte functional assay 
experiment. The initial flow rate of oil solution was kept low compared with the 
cell and buffer solutions. This was to prevent oil from back-flowing into the cell 
guiding array. The microfluidic devices were mounted on an inverted 
microscope (Olympus IX81, Japan) equipped with a high speed camera 
(Phantom, USA) for flow investigation. The droplets stored in observation 
chamber were imaged under another epi-fluorescent microscope (Olympus 
IX83, Japan) equipped with a CCD camera (Retiga 2000R, QImaging, Canada). 
High speed videos and fluorescent images captured from the integrated device 
and observation chamber were then analyzed using ImageJ® software 
(https://imagej.nih.gov/ij/, National Institute of Health, USA). For viability 
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evaluation, the fluorescent images of nucleus staining (blue) and dead staining 
(red) was converted into binary images by thresholding with Otsu filter. The 
resulting images was then counted using the “analyze particle” function of 
ImageJ® with pre-defined cell size range. The numbers of particles obtained 
from nucleus and dead staining images were regarded as total cell number and 
dead cell number. 
 
5.2.5 Immunofluorescence staining and FACS analysis 
Leukocytes extraction efficiency of the device and composition of retrieved 
leukocytes were measured using flow cytometer (Accuri C6, Becton Dickinson, 
USA) on the collected samples. Oil solution was not used in all FACS-related 
experiment. Washed leukocytes directly exited the microfluidic device from 
droplet outlet and the debris and contaminants exited from the waste outlet. 
Before experiment, freshly retrieved leukocytes were incubated with 
phycoerythrin (PE) conjugated CD45 antibody (1:10, Miltenyi Biotec Asia 
Pacific, Singapore) for 15 minutes, followed by washing to remove unbound 
antibody. Immunofluorescence staining allowed discrimination of leukocytes 
from other debris and enumeration of the number of leukocytes from collected 
samples. Together with side scattering (SSC) signals, granulocytes and 
agranulocytes could be distinguished effectively based on their different cell 
granularity. During FACS analysis, leukocytes were gated based on CD45 




5.2.6 Droplet-based MMP assay 
The protease detection experiment was done by encapsulating leukocyte 
together with MMP substrate, the same as described in the chapter 4. Matrix 
metalloproteinase activity were assayed using FRET-based substrate 
Pepdab010 (Biozyme Inc, USA), which is sensitive to MMP-9 and ADAM-17. 
The concentration of the substrate solution was 20 µM. Fluorescent signal of 
cell-containing droplets was collected after 1-hour droplet incubation. 
 
5.3  Results and discussion 
5.3.1  Laminar flow verification 
Fluorescein isothiocyanate (FITC) dye was used to validate laminar flow 
condition in the cell washing channel. 100nM FITC solution was injected in the 
device together with PBS buffer. The flow profile was monitored by measuring 
the fluorescence intensity across the microchannel at three different locations 
(inlet, middle of channel and outlet bifurcation) as shown in Figure 5.5. The 
fluorescent images in Figure 5.5 (B) and the quantified fluorescence intensity 
shown in Figure 5.5(C) demonstrated that fluorescent dye solution was well 
confined to one side of microchannel throughout the whole washing section. 
The presence of micropillars did not affect the laminar flow consistency. It was 
observed that the slope of fluorescence intensity profile across the channel width 




Figure 5.3 (A) Device image with dye injected into the microchannel. (B) FITC 
dye (100 nM) flowing in the channel parallel with PBS buffer at 1) inlet, 2) 
middle section and 3) bifurcation point. (C) Measured fluorescence intensity at 
3 channel locations as shown in (B).  
 
5.3.2  Diffusion characterization on enzyme and substrate 
After validating with fluorescent dye, the diffusion of biomolecular 
contaminants was further characterized using MMP substrate and trypsin, which 
could cleave the MMP substrate at high reaction rate [101]. Trypsin has a 
molecular weight of 23.3kDa, which is closer to matrix metalloproteinases 
compared with FITC dye. In the microchannel, trypsin and substrate diffused 
against each other and reacted at once when they were in close proximity. When 
the substrate was cleaved by trypsin, fluorophores would be released to form a 
bright band along with flow direction. As the cleavage rate of trypsin against 
substrate is very high, the rate limiting factor of the overall fluorogenic reaction 
was the diffusion of trypsin and substrate molecules. Hence, the diffusion zone 
of trypsin and substrate molecules could be identified by monitoring the bright 
fluorescent band in the microdevice.  
Two sets of experiments were conducted to investigate the diffusion effect. First, 
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the flow ratio of trypsin and substrate was fixed at 1:1 while their flow rate was 
scaled up gradually. Based on the fluorescent images in Figure 5.6 (A) to (C), it 
was observed that higher flow rate resulted in narrower fluorescent band, 
indicating the smaller diffusion occurred in the microchannel due to shorter 
diffusion time. Based on the quantified result shown in Figure 5.6(D), the width 
of fluorescent band at 150 a.u. shrank from 275.8 to 116.0 µm as the total flow 




Figure 5.4 (A) (B) (C) Fluorescent images of flowing trypsin and fluorogenic 
substrate at 1:1 flow ratio near the bifurcation point. Higher total flow rate 
corresponds to dimmer and narrower fluorescent band, suggesting less diffusion 
occurred. (D) Quantified fluorescence intensity of three flow conditions with 
1:1 flow ratio. (E)(F)(G) Fluorescent images of flowing trypsin and fluorogenic 
substrate at differential flow rates near the bifurcation point. The location of 
fluorescent band can be adjusted by the differential flow rates. (H) Quantified 
fluorescence intensity of three conditions with differential flow rates.  
 
Different flow rates were also applied to investigate how diffusion zone could 
be shifted based on differential flow ratio. Based on the experiment results, it 
was observed that the position of fluorescent peak could be easily adjusted by 
controlling the flow rate as shown in Figure 5.6(E) to (G). High flow rate of the 
substrate solution shifted the fluorescent peak towards the trypsin solution and 
far away from the bifurcation point as shown in Figure 5.6(H). Therefore, high 
flow rate of washing buffer, compared with cell solution, was deployed in the 
single leukocyte study project in order to stop contaminants diffusing into the 
droplet generator 
 
5.3.3  Leukocyte viability characterization  
After diffusion characterization, it seemed high flow was desirable for diffusion 
suppression. However, high flow could make leukocytes subject to high shear 
rate and heavy collision impact with guiding micropillar, which may affect 
leukocyte viability. Hence, we conducted a cell viability test to investigate the 
relationship between cell survival rate and flow rate. The viability of cell was 
monitored at two time points, 1) right after the cells exited the washing channel 
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2) after 1-hour incubation at the room temperature to mimic the duration of the 
functional assay. The viability test was conducted in the normal buffer solution 
without droplet formation. Because of large droplet size and good oxygen 
solubility in the fluorocarbon oil [127], the viability measured in the buffer 
environment was a reasonable estimation of the real viability inside water-in-
oil droplet for short period of time.  
The immediate viability of fresh leukocytes after passing through the DLD-
based washing channel remained around 90% for all flow conditions as shown 
in Figure 5.7. However, after 1-hour incubation the unwashed leukocytes in the 
control group demonstrated an overall viability of 89.9%. The measured 
viability of cells flowed at 5 µL/min was 91.2%. Nevertheless, the overall 
viability under 10, 20 and 40 μL/min flow rates reduced to 85.1%, 82.7% and 
82.2%, respectively. This decreasing viability with increasing flow rate 
indicated that the high shear force and fierce collision with micropillar under 
high flow rate did compromise the survival rate of fresh leukocytes, which could 
inevitably affect the accuracy of the following single-cell functional assay. In 
order to ensure that cells remained their original status as much as possible after 
washing, the flow rate for the subsequent functional assay was controlled below 




Figure 5.5 (A) Brightfield and fluorescent images (blue: nucleus stain; red: dead 
stain) of leukocytes after passing through the washing channel at 5 μL per 
minute. (B) Quantified viability rate of cells at t=0 and t=1-hour after passing 
the device at different flow rates.  
 
5.3.4  Washing channel design and beads test  
DLD has been well studied to separate particle from based on the size difference. 
Two formulae have been derived to calculate the critical separation dimension. 
The first one is the analytical formula that has been discussed in Chapter 3 [100]. 
The second version is known as empirical formula based on separation results 
obtained from more than 20 devices with varying channel design [151]. The 
empirical formula, unlike the analytical formula, does not contain a correction 
factor. The empirical formula has been proved to generate a more accurate 
predication of critical separation dimension of DLD array than the analytical 
model [152]. Its separation cut-off dimension depends on the array slant angle 
and lateral gap size between pillars in the same row as shown below,  
 𝐷𝑐 = 1.4𝑔𝜀
0.48 (5.1) 
Where Dc is the critical dimension of particle for DLD separation, g is the lateral 
gap size and ε is the row shift fraction (ε = tanθ = ∆λ/λ, where θ is the array 
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slant angle, ∆λ is the row shift distance and λ is the center-to-center lateral 
distance between micropillars) [151]. For this project, the empirical formula 
was adopted into the device design. 
In order to effectively retrieve fresh leukocytes from RBC-lysed blood, the 
separation threshold dimension was set 10 μm given the fact that average size 
of leukocytes is about 12 μm. In the first design, the pillar dimension and lateral 
pillar gap (g) was set 30 μm. The row shift distance was set 2.4 μm, resulting in 
row shift fraction (ε) equal to 0.04. The empirical cut-off separation dimension 
would be 8.96 μm. However, when testing with polystyrene beads, the cell 
washing device could only divert beads over 15 μm from the original solution 
into the washing solution. This DLD design had no influence on the trajectory 
of 10 μm beads as they were still refined in the original solution.  
At first, it was believed that microfabrication error led to sorting failure. The 
measured diameter of micropillar was 27.21 ±1.37 μm rather than 30 μm, 
because of UV overexposure. As a result of shrinking micropillar diameter, the 
effective gap size would expand and increase the separation cut-off dimension. 
In order to have better tolerance of microfabrication error, the row shift distance 
was adjusted to 1.5 μm with empirical cut-off dimension equal to 7.1 μm in the 
second design. However, 10 μm beads still moved directly into the waste outlet 
without deflection in the adjusted design. Although the microfabrication error 
could cause 5 to 10 % increase of gap size, this error was unable to increase the 
separation cut-off dimension by 3 μm. Hence, the empirical formula was not 
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accurate for Dc ≤ 10 μm.   
The critical separation dimension must be reduced further in order to effectively 
deflect 10 μm polystyrene bead and white blood cell. To achieve this, either the 
gap size (g) or the row shift distance (∆λ) must be reduced based on the 
empirical model. However, neither of them was favorable. On one hand, 
reduced gap size could make the DLD-based cell washing array vulnerable to 
clogging due to bead/cell cluster. On the other hand, decreased row shift 
distance could unavoidably increase the channel length because of the reduced 
slant angle. Additionally, such a small row shift distance could pose challenges 
on the precision of microfabrication. Since neither gap size nor row shift 
distance could be reduced further with the consideration of device operation and 
fabrication, new parameter that was not covered in analytical and empirical 
formulae must be exploited to decrease the cut-off dimension.  
In fact, the distance between neighboring columns of micropillar (λv) is always 
assumed to be identical to the lateral distance (λ) between micropillars in the 
same column in both DLD analytical and empirical model, as shown in Figure 
5.8(A)-middle. Nevertheless, the asymmetric micropillar array with unmatched 
λv and λ could have different critical separation dimension deviating from the 
existing models. In general, when λv becomes smaller than λ, the critical cut-off 
dimension for separation reduces and vice versa. In the extreme scenario, when 
λv reaches 0, the DLD array effectively becomes into an array of closed channels 
where particles of any size would be definitely diverted from one side to the 
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other; and when λv is too large, the DLD array would have no sorting effect on 
particles no matter of their size, because particles could recover to their original 
trajectory after bumping to micropillars. Some DLD-based platforms have 
exploited the relationship of λv and Dc to achieve optimal sorting efficiency 
[153, 154]. Therefore, beads sorting experiment was conducted with new DLD 
design of reduced λv. Eventually, it was observed that 10 μm beads could be 
effectively diverted when λv was reduced to 15 μm with λ, g and ∆λ remaining 
as 60, 30 and 1.5 μm, respectively. As shown in the figure 5.8(B), it was clearly 
observed that both 10 and 15 μm polystyrene beads could be successfully 
directed from the original solution (lower stream) into washing solution (upper 
stream) and 7 μm beads kept moving straight into waste outlet. 
 
Figure 5.6 (A) Schematics showing the relationship between vertical pillar 
distance (λv) and critical separation dimension (DC). DC is positive correlated 
with λv as increasing λv leads to increasing DC. (B) Overlaid images of 
polystyrene beads moving in the DLD-based cell washing channel: left 7.5 μm 
beads demonstrated no deflection and remained in the lower stream; middle and 
right 10 and 15.5 μm beads demonstrated a lateral migration toward upper 




5.3.5  Leukocyte flow test and FACS characterization post-washing 
Next, freshly harvested leukocytes were tested using the optimal device design. 
Figure 5.9 illustrates the moving trajectory of fluorescent-labelled leukocytes at 
different locations in the cell washing channel. Leukocytes, like 10 μm 
polystyrene beads, kept bumping to circular micropillars in the microchannel 
and were forced to leave the original cell solution, enter the clean buffer solution 
and be encapsulated into droplets. Meanwhile, RBC debris and other molecular 
contaminants were still confined in the original cell solution and eventually 
exited the device from waste outlet.  
 
Figure 5.7 Phase contrast images of leukocytes in the microfluidic device (A) 
Labeled leukocytes entered the cell washing array at one inlet. (B) Leukocytes 
started to migrate into the clean buffer solution as they passed through the cell 
washing channel. (C) Most of leukocytes entered the droplet branch after 
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washing while some small cells and debris escaped into the waste outlet. (D) A 
washed leukocyte was encapsulated into droplet with clean buffer. 
 
The cell solution and waste solution were collected for cell count and FACS 
analysis to investigate leukocyte extraction efficiency and cell composition. 
According to the cell concentration and volume of the solutions collected at 
droplet and waste outlets, the leukocyte recovery rate was calculated as 82.7% 
when flow rates of buffer and cell solution were set 5 and 4 µL/min, respectively. 
The average leukocyte recovery rate was about 80% at various flow rate as 
shown in figure 5.10(A). The main reason of cell loss might be because some 
leukocytes, like lymphocytes, was unable to be guided into buffer solution due 
to their small size [155].  
In order to verify this hypothesis, FACS analysis was performed to investigate 
the cell composition of the samples collected from both outlets. Due to the 
different cellular structure of nucleus and presence of granules, granulocytes 
(mainly neutrophils with small number of eosinophils and basophils) generate 
a higher side-scattering (SSC) signal than lymphocytes and monocytes under 
FACS scan [156]. Figure 5.10 (C) and (D) demonstrate the FACS scan results 
obtained from cell and waste outlet. Gate P1 indicated the granulocytes 
population since the cells carried positive CD45 and high SSC signals. Gate P2 
indicated the lymphocytes and monocytes population since the cells falling in 
this gate had positive CD45 but low SSC signals. Based on the FACS results, it 
was confirmed that the majority of cell population extracted from the cell 
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washing channel were granulocytes. The granulocytes-to-agranulocytes ratio of 
unsorted control sample was about 2.15:1. The ratio of sample collected from 
the cell outlet was about 2.81:1 while it decreased to 0.57: 1 for sample obtained 
from the waste outlet (Figure 5.10(B)). Thereof, the developed device owned a 
selectivity of granulocytes over agranulocytes due to the size-based sorting 
(granulocytes: 12~17 µm, monocytes: 15~30 µm, lymphocyte: 7~13 µm). 
Many lymphocytes escaped into the waste outlet because of their small size.  
An even better granulocyte purity could be achieved if increasing the critical 
separation dimension of the cell washing channel with the risk of losing more 





Figure 5.8 (A) Leukocyte recovery rate at different flow ratios. An average 
recovery rate of 80% was obtained, with about 20% leukocytes loss. (B) 
Measured granulocytes-to-agranulocytes ratio of samples collected from 
different device outlets, suggesting an enhancement of granulocytes due to size-
based sorting. (C) and (D) Flow cytometry results of cell collected from both 
droplet outlet (C) and waste outlet (D). P1 gate indicated the granulocyte 
population; P2 gate indicated the monocyte and lymphocyte population; and P3 
gate indicated the cell debris and other acellular contaminant.  
 
5.3.6  Protease assay of single leukocytes 
Matrix metalloproteinase (MMP) activity of individual live leukocytes was 
analyzed using the developed device, which was difficult to measure with 
conventional droplet technology due to pre-encapsulation contamination. As 
shown in Figure 5.1 (C), the fluorescence intensities of empty and leukocyte-
containing droplets were very close (difference was less than 20 a.u.). With the 
spontaneous cell washing mechanism, the functionality level of single 
leukocytes could be accurately assayed in the individual water-in-oil droplets.  
As a proof-of-concept, MMP substrate was pumped into the microfluidic device 
as the washing buffer with leukocyte solution.  
We first studied the MMP activity level of single leukocytes at naïve status. 
Leukocyte-containing droplets with different fluorescent intensities (Figure 
5.11(A)) showed the cells had a diverse level proteolytic activity at naïve status. 
The quantified results shown in Figure 5.11(B) showed the heterogeneous 
proteolytic profile with a mean fluorescence intensity of 136.3 a.u. and standard 
deviation of 54.6 a.u. The two clusters (around 60 a.u. and 175 a.u.) in the 
fluorescence intensity were identified from the scattered plot of a population of 
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leukocytes, which may be contributed by two different subpopulations of 
leukocytes (i.e. granulocytes and agranulocytes). Monocytes have been 
demonstrated with low MMP expression and activity level at naïve status in 
previous studies [157]. Excitingly, we also found the fluorescence intensity 
level of empty droplets was largely reduced from 96.9 ± 6.7 a.u. to 23.4 ± 4.9 
a.u. due to the washing function integrated before cell encapsulation as shown 
in Figure 5.11(C). The reduced noise signal made empty droplets easily 
distinguishable from leukocyte-encapsulated droplets.  
Next, 1 μM of phorbol 12-myristate 13-acetate (PMA) was introduced into the 
MMP substrate to study the MMP activity level of fresh leukocytes under PMA 
stimulation. In previous literature, PMA has been proved to boost the MMP 
activity on cultured cancer cells [62]. Before single-cell experiment, viability 
test on 1 μM PMA mediated leukocytes was conducted to ensure that PMA did 
not have an adverse effect on cell survival rate for 1-hour incubation. In the 
single leukocytes experiment, we observed the elevated MMP activity after 
incubating single leukocytes with 1 μM PMA in droplets for 1 hour. The mean 
fluorescence intensity increased to 416.8 a.u., which was 2-fold higher than the 
mean intensity obtained at naïve condition. Meanwhile, the standard deviation 
of fluorescence intensity also increased by 1 fold to 104.7 a.u., suggesting the 
heterogeneity of MMP activity level of single leukocytes was intensified after 
PMA stimulation. This intensified heterogeneity of single-cell profile under 
PMA mediation was originally difficult to be captured by average-based 
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ensemble measurement. In addition, it became difficult to identify 2 signals 
clusters after PMA stimulation, which may suggest the effect of MMP elevation 
was greater on monocytes than on granulocytes, resulting in overlapped MMP 
signal intensity.  
 
Figure 5.9 (A) Brightfield and fluorescent images of leukocyte-containing and 
empty droplets produced by normal droplet generator and developed device. 
Empty droplets have different fluorescent signals under two scheme (B) 
Comparison of fluorescence intensity of empty droplets generated from normal 
droplet generator and the developed device with washing function. The intensity 
of empty droplet was reduced by 4 times due to the implementation of pre-
encapsulation washing. (C) Brightfield and fluorescent images of single 
leukocyte-containing droplets under naïve status. Different fluorescent 
intensities can be clearly observed at the single leukocyte level. (D) Quantified 
fluorescence intensity for single leukocyte-containing droplets under both naïve 
and 1 µM PMA-mediated condition. PMA treatment apparently lifted the MMP 





5.4  Conclusions 
An integrated microfluidic device combining cell washing section and droplet 
generator was developed for single leukocyte functional study. The DLD-based 
washing channel could divert leukocytes from cross-contaminated solution to 
clean buffer solution and guide the washed leukocytes to enter droplet generator 
while directing contaminants and debris to the waste outlet. The flow condition 
was carefully characterized in order to minimize the diffusion of molecular 
contaminants and the viability loss of fresh leukocytes. The developed device 
demonstrated around 80% leukocyte recovery rate with a selectivity of 
granulocytes over monocytes and lymphocytes. The MMP activity of individual 
leukocytes was measured by detecting the fluorescent signal generated from 
cell-containing droplets. At the naïve status, the MMP profile revealed a 
heterogeneous activity level with two clusters that may be contributed by 
different subpopulations of leukocytes. PMA-mediated MMP activity was also 
successfully measured at single leukocyte level. After 1-hour incubation with 1 
µM PMA in the droplet environment, the MMP activity was intensified with 2-
fold increase in the average fluorescence intensity and diversified with 1-fold 
increase in the spread. We believe the developed single cell assay platform is 
ideal for the functional analysis of highly active cells from an impure and cross-
contaminated solution due to the washing-immediately-before-encapsulation 
function. With further development, the microfluidic device can be used for 
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quick evaluation of patient immunity and immune response to different drugs 





Chapter 6. Conclusions and future work 
6.1  Conclusions 
No two cells are exactly alike. Each cell has its distinct phenotype, behavior and 
function even when compared to other cells from the same lineage or sharing 
the same gene. However, conventional biological assays, such as western blot 
and ELISA, adopt a simplistic method to extract the average prevalent cell 
signals from non-homogeneous cell population. The average behavior of a cell 
population is summarized by a mean value, without considering cell-to-cell 
differences. Today more scientific evidences have pointed out cellular 
heterogeneity can have functional consequences and a population average can 
generate misleading assay outcomes because of neglecting critical details of 
individual cells. 
Single-cell assay is essential in order to enable scientists to capture cell-to-cell 
variance beneath population average of seemingly identical cells. In general, 
conventional macro-scale single-cell analytical approaches are seriously 
constrained by high system cost, low assay throughput, low detection sensitivity 
and heavy sample/reagent consumption. In contrast, microfluidics offers a 
simple but versatile approach to perform single-cell analysis. Individual cells 
are isolated from each other in the single-cell compartments for various 
downstream applications. Among all microfluidic single-cell approaches, 




In this dissertation, we focused on the development of droplet microfluidic 
platform for single-cell proteolytic assay. Proteolytic activity at single-cell level 
provides important insights of cellular heterogeneity which in turn aids in 
accurate cell behavior evaluation and precise personalized medicine in cancer 
and immune disorder.  
We first developed an integrated droplet platform combining jetting and passive 
sorting. We used this novel platform to improve the poor single-cell efficiency 
of random encapsulation process. The achieved single-cell encapsulation 
efficiency was consistently above 70% for various cell concentrations, which 
beat the Poisson prediction. The enhanced encapsulation efficiency could 
largely facilitate the downstream assay, particularly for low input cell 
concentration. The entire process was label-free so the original cell status could 
be successfully preserved to the maximum extent. Single-cell proteolytic assay 
and drug test were performed on cultured cell lines using the developed platform.  
Next, we further developed the droplet platform to make it more reliable and 
accurate. Combined with in vitro circulating tumor cell (CTC) culture, the 
droplet platform could realize single-cell proteolytic assay on cultured CTCs, 
which were expanded from cancer patients. In the system characterization, we 
studied 3 breast cell lines and found that the metastatic cancer cell line possessed 
an elevated level of matrix metalloproteinase (MMP) activity, compared with 
the non-metastatic cancer cell line and the normal epithelial cell line. Then we 
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applied the assay method on cultured CTC sample. The results revealed cultured 
CTCs were very heterogeneous in MMP activity and different batches of 
cultured CTCs had distinct MMP profiles even through the CTC donors were in 
the same stage of cancer treatment.  
While studying cultured CTCs, we found leukocyte residue was always present 
in the culture sample. Hence, we decided to perform a comprehensive study on 
single leukocytes. Unlike cancer cell, leukocytes are highly active in protease 
secretion due to their responsibility in host defense. In order to prevent pre-
encapsulation contamination, we developed a droplet generator with cell 
washing function. Freshly-retrieved leukocytes were diverted into a clean buffer 
solution from the impure cell solution in the washing channel and immediately 
encapsulated into droplets. Using this developed platform, the background 
signal in empty droplets was largely suppressed and the proteolytic assay 
accuracy was significantly improved. We successfully applied this platform to 
study MMP activity of leukocytes at naïve and PMA-mediated conditions, 
finding PMA treatment not only intensified the single-cell MMP activity but 
also stimulated the cell-to-cell variance.  
In conclusion, we have shown that functional assay of matrix metalloproteinase 
produced by single cancer cells and leukocytes can be achieved using droplet 
microfluidics. Compared with other single-cell analytical methods, the droplet 
microfluidic systems possess high detection sensitivity, low cross-
contamination, minimum interference on cells and scale-up potential. With 
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further development, we believe that the droplet technologies presented in this 
work could be applied in the clinical practice to evaluate patient and disease 
status, and eventually benefit the medical community. 
  
6.2  Future work 
The future work for single-cell proteolytic functional assay can be expanded in 
three directions: improvement on fluorescent detection, multiplexed signal 
detection and clinical application on diseased cell characterization.  
The scheme of fluorescent detection can be modified to handle large volume of 
sample with relatively high throughput. Current detection was conducted under 
a stationary condition, which limited the detection throughout by the 
microscopic observation window. Continuous high-throughput droplet 
detection has been reported long ago [158]. By adopting this detection method, 
it will be easy to study hundreds of thousands of droplets to generate clinical 
conclusions within a short duration. Apart from throughput, a more rigorous 
calibration on fluorescent measurement can be helpful to produce more 
consistent single-cell proteolytic assay results. As fluorescent based detection is 
sensitive to environmental and other factors, such as ambient brightness and 
intensity fluctuation of fluorescent light source, a fluorescent calibration before 
droplet detection using some reference subjects (e.g. dye solution or fluorescent 
bead) can ensure experimental condition is coherent across different sets of 
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experiments.   
Secondly, only one MMP substrate has been used to detect single-cell 
proteolytic activity in this PhD project. As mentioned before, the MMP 
substrate is not specific to any kind of MMPs. A more accurate and specific 
detection could be realized based on multiplexed MMP assay, where multiple 
substrates are injected into droplets and different signals are acquired at the 
same time [68]. By de-convoluting the multiplexed signals, the activity level of 
specific types of MMPs could be derived correctly with great biological 
significance. 
Lastly, more clinical samples can be studied using the developed droplet 
platform. In this work, we only emphasized on cancer cells and leukocytes. 
Single-cell proteolytic activity has a broad clinical implication. Hence, it will 
be meaningful to expand the application beyond the current scope. Definitely, 
the detection targets can include other biomarkers (e.g. metabolism) to form 
multiplexed single-cell droplet assays. These aspects of future work require 
various multidisciplinary collaboration for fruitful research. But I firmly believe 
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